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Sialic Acid Modulation Of Cardiac Voltage-Gated Sodium Channel Gating 
Throughout The Developing Myocardium 
Patrick J. Stocker 
ABSTRACT 
 
     The proper orchestration of voltage-gated ion channel gating is vital to 
maintaining normal heart rhythms throughout an animal’s lifespan.  Voltage-
gated sodium channels, Nav, are responsible for the initiation of the cardiac 
action potential, which leads to cardiac systole.  Comparison of neonatal 
ventricular and atrial myocyte Nav gating with adult indicated that the neonatal 
ventricular Nav gated following a ~10 mV greater depolarization than did atrial or 
adult ventricular Nav.  In this study I questioned whether development- and/or 
chamber-dependent changes in Nav-associated functional sialic acids could 
account for these differences.  When desialylated with neuraminidase, all gating 
characteristics for the lower voltage activated atrial and adult ventricular Nav 
shifted significantly to more depolarized potentials.  However, desialylation of the 
higher voltage activated neonatal ventricular Nav had no effect on channel gating.  
Furthermore, channels were stripped of their N-glycosylation via PNGase-F in an 
attempt to separate the potential effects of the remaining glycosylation structure 
on Nav gating.  Following treatment, neonatal ventricular Nav gating remained 
unchanged while atrial and adult ventricular Nav gating again shifted to 
 ix 
 
depolarized potentials nearly identical to those of the neonatal ventricular 
channel.  Immunoblot analyses indicated that atrial and adult ventricular Nav α 
subunits are more heavily sialylated than the neonatal ventricular α subunit, with 
approximately 15 more sialic acid residues.  The data indicate that differential 
sialylation of myocyte Nav α subunits is responsible for much of the 
developmental and chamber-specific remodeling of Nav gating observed here.  In 
addition, the Nav1.5 α subunit can associate with β subunits, also believed to be 
sialylated.  The potential for functional β1 trans sialic acids to further modulate 
Nav1.5 gating was tested via co-transfection of β1 with the Nav1.5 α subunit into the 
Pro5/Lec2 mammalian expression system.  Co-transfection revealed that the 
additional β1 trans sialic acids caused a hyperpolarizing shift in all tested gating 
parameters.  When transfected into neonatal ventricular myocytes, β1 expression 
revealed no effect, implying that β1 expression alone is not responsible.  
Together, the myocyte and expression system studies describe a novel 
mechanism by which Nav gating, and subsequently cardiac excitability, are 
modulated by the regulated change in channel-associated functional sialic acids.   
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Introduction 
 
Ion transport 
     Ion transport from one side of a cell membrane to another is an important 
element in many processes like nerve transduction, muscle contraction (cardiac, 
skeletal, smooth), neurotransmitter release, nutrition absorption, and 
maintenance of the cellular membrane potential.  To accomplish this movement 
of ions many different protein mediated transport mechanisms such as ion 
exchange, active transport, secondary active transport, leak, stretch-activated, 
ligand-gated, and voltage-gated ion channels exist.   
     For ion exchange mechanisms, each set of ions move down their 
electrochemical gradient, produced through the combination of the ion’s 
concentration gradient and electrical driving force.   Some popular examples of 
these transporters are Na+ / Ca2+, Cl- / HCO3-, and Na+ / H+ exchangers (figure 1).  
The transport protein in question associates with its specific ions on each side of 
the membrane and then the ions are swapped from one side to the other.  Active 
transport is the movement of solutes from one side of the membrane to the other 
against that solute’s concentration gradient.  Fueled by the hydrolysis of ATP, the 
Na+ / K+ ATPase helps to maintain a cell’s resting membrane potential, regulated 
by intra and extracellular Na+ and K+ concentrations, by transporting three Na+ 
outside and two K+ inside the cell (figure 2).  Secondary active transport is fueled  
 2 
 
Figure 1:  Ion exchange transport proteins 
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Figure 1:  (continued)  
 
Facilitated transport proteins exchange one ion for another from one side of the  
membrane to the other. 
A:  Na+ / Ca2+ ion exchanger  
B:  Cl- / HCO3- ion exchanger 
C:  Na+ / H+ ion exchanger 
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Figure 2:  Active transport 
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Figure 2:  (continued) 
 
A schematic example of active transport using the Na+/K+ ATPase to move Na+ 
and K+ against their concentration gradients.   
Step 1:  Na+ binds to the cytoplasmic open face of the transport protein.  Step 2:   
ATP is hydrolyzed to ADP phosphorylating the protein.  Step 3:  The Na+ bound 
phosphorylated protein opens to the outside releasing the Na+.  Step 4:  K+ binds 
to the open extracellular face of the phosphorylated transport protein.  Step 5: 
The protein becomes unphosphorylated.  Step 6:  The unphosphorylated protein 
opens to cytoplasmic side of the membrane releasing the K+ allowing for the 
cycle to start again. 
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by the energy resulting from one solute’s movement from one side of the 
membrane to the other down its chemical gradient.  This supplied energy is used 
to co-transport other solute molecules against their chemical gradients, as in the 
case of glucose absorption in the gut and kidneys together with Na+ ions (figure 
3). 
     Ion channels are a second type of transmembrane protein that creates 
permeation pathways for ions to cross membranes.  These proteins form 
aqueous pores in the membrane that, with the use of a selectivity filter, allow 
specific ions to pass through from one side of the membrane to the other.  When 
an ion is allowed to pass through a channel, it flows down its electrochemical 
gradient requiring no energy expenditure.  Ion channels fall into four general 
categories based on their mode of activation, leak, stretch-activated, ligand-
gated, and voltage-gated.  Leak channels are exactly that, channels that are 
believed to be constitutively active.  Typically involved in maintaining the resting 
membrane potential, leak channels are active most of the time creating a 
permeation pathway for a specific ion (Plant et al., 2005;Tamargo et al., 2004).  
Stretch-activated channels are believed to open in response to plasma 
membrane stretch.  Once stretched the protein changes conformation to create 
an aqueous pore through which ions can flow.  Their functions are not totally 
understood but are believed to be involved in the regulation of cell volume 
(Zagorodnyuk et al., 2005;Kalapesi et al., 2005;Trayanova et al., 2004).  Ligand-
gated channels are thought to be closed at rest; following binding of a ligand to 
the channel, neurotransmitters for example, the channel opens (figure 4).   
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Figure 3:  Secondary active transport of Na+ and glucose in the small intestine 
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Figure 3:  (continued) 
 
Co-transport of one molecule accomplished by using the energy released 
through the transport of a second molecule. 
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Figure 4:  Neuromuscular junction 
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Figure 4:  (continued) 
 
Close up illustration of the neuromuscular junction showing Acetylcholine being 
released from the axon and traveling across the synapse to the ligand-gated Ach 
receptor binding sites to thus result in channel opening and eventual muscle 
contraction. 
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Acetylcholine (Ach) receptors at the neuromuscular junction are a good example 
of ligand-gated ion channels.  Ach is released by the motor neuron into the 
synapse and becomes bound to motor endplate Ach receptors changing them 
from closed to open.  Once Na+ moves down its electrochemical gradient 
depolarizing the membrane this depolarization then triggers what are known as 
voltage-gated ion channels.  Voltage-gated ion channels are membrane proteins 
that open in response to a membrane depolarization.  Typically, when a cell 
membrane is at its resting membrane potential, the channel is in its closed 
conformation.  When the membrane becomes more depolarized the channel 
senses this change in potential, opens, then allows selected ions to pass 
through.  Following the open state most voltage-gated ion channels then rapidly 
close, voltage-gated K+ channels for example, while others move into a third 
state called inactivation, voltage-gated Na+ channels for example, rendering it 
unlikely for the channel to then be reactivated (figure 5).  Once the Ach receptor 
induced Na+ mediated membrane depolarization opens the voltage-gated Na+ 
channels, Na+ moves down its electrochemical gradient through the open 
channels into the cell further depolarizing the surrounding membrane.  When the 
membrane potential has become depolarized enough to reach what is known as 
the threshold potential, an action potential is the result.  Once an action potential 
has been triggered, the membrane depolarization spreads to the surrounding 
areas and has a similar effect on the voltage-gated ion channels in the area, thus 
propagating the signal and ultimately resulting in muscle contraction.  In addition, 
the membrane depolarization of the spreading action potential has now also  
 12 
 
Figure 5:  Schematic representation of a voltage-gated Na+ channel 
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Figure 5:  (continued) 
 
In segment A is a voltage-gated Na+ channel in the closed state.  When moving 
to segment B the membrane begins to become depolarized being sensed by the 
channel voltage sensors.  In segment C the channel has moved from the closed 
to the open state allowing Na+ to flow through.  Following segment C for some 
channels, K+ for example, the channel would then move back into the closed 
state ready to be used again.  In this case, the Na+ channel moves into a third, 
inactivated state (segment D) when a channel inactivating segment blocks the 
open channel pore.  Following membrane repolarization the channel moves back 
into the closed state, segment A, ready to refire again. 
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activated voltage-gated K+ channels.  This allows K+ to move out of the cell, 
opposing the inward Na+ current, repolarizing the membrane back to its resting 
potential and resetting the system to receive and transmit further signals. 
 
Voltage-gated Na+ channels 
     Voltage-gated Na+ channels, Nav, are responsible for the initiation and 
propagation of action potentials in excitable tissues, opening rapidly and then 
inactivating following a membrane depolarization (Hille, 2001).  The orchestrated 
activation and inactivation of Na+ channels is vital to normal skeletal muscle and 
neuronal function, and in maintaining normal heart rhythm.  To date ten different 
voltage-gated Na+ channel isoforms have been identified. Nav nomenclature 
derived to identify the different isoforms is Nav1.1 to Nav1.9 with the tenth being 
labeled Nax (figure 6) (Goldin et al., 2000).  Each Nav isoform shares greater than 
50% identity with the other Nav family members.  One important fact to note 
when considering the following description is that, to date, no one has been able 
to crystallize a voltage-gated Na+ channel in its complete membrane incorporated 
functional quaternary structure.  This current limitation has led to a generally 
agreed upon structure of functional membrane bound voltage-gated Na+ 
channels as elucidated from the efforts of channel biologists worldwide.  Nav are 
sodium specific ion channels that are made up of a single polypeptide chain 
forming the α subunit.  This chain weaves in and out of the membrane twenty-
four times forming 4 distinct domains made up of six membrane-spanning 
segments each (figure 7).  The S4 segment of each domain contains a positively  
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Figure 6:  A chart outlining the known voltage-gated Na+ channel α subunits  
 
along with their corresponding anatomical locations (Goldin et al., 2000) 
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Figure 7:  Nav1.5 voltage-gated ion channel 
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Figure 7:  (continued) 
 
Voltage-gated Na+ channels are made up of four homologous domains each with 
six membrane spanning alpha helical segments with the fourth alpha helices 
being the voltage sensors.  The protein loops between each S5 and S6 segment 
are believed to create the channel pore.  The intracellular loop between the third 
and fourth domain is the channel inactivation segment.  Represented by pitchfork 
structures on the large extracellular loop of the first domain are N-linked 
glycosylation structures. 
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charged amino acid in every third position.  These S4 segments are believed to 
make up what is referred to as the channel voltage sensor.  The S4 amino acids 
are thought to move from the inner surface of the membrane toward the outer 
surface, repelled by the membrane depolarization, resulting in the conformation 
change of the protein moving the channel from the closed to the open state.  The 
way in which the S4 segments are believed to be orientated and their motion in 
response to a membrane depolarization has been a recent topic of debate.  Over 
the years it has been assumed that the S4 segments are embedded within the 
quaternary structure in four cylindrically shaped alpha helices surrounding the 
channel pore.  Through work done studying crystallized segments of voltage-
gated K+ channels, which are homologous to Nav, it has now been suggested 
that the S4 segments may actually form four paddle-like structures branching to 
the outside of the channel rather than being embedded within it (Jiang et al., 
2003a;Jiang et al., 2003b).  Regardless of their orientation, it is still believed that 
the S4 segments are close to the inner membrane surface at rest moving 
towards the outer surface following a membrane depolarization.  The intracellular 
linker between the third and the fourth domains is known as the fast inactivation 
loop, made up of an IMF motif (isoleucine, methionine, phenylalanine).  It is this 
IMF motif of the loop that is believed block the channel pore moving it from the 
open to inactivated state.  During the inactivation period it is unlikely for the 
channel to become opened again until the system is reset.  Finally, for the 
channel to move from the inactivated back to the closed state allowing the 
channel to again be activated, the membrane must become hyperpolarized 
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again.  The hyperpolarization of the membrane back to its resting potential drives 
the channel to reset back to the closed state now ready to be used again.  It is 
important to recognize that this is a simplified description of Nav channel gating 
and a more thorough explanation of the intricate details surrounding channel 
gating can be found in many other literary works (e.g., Ion Channels of Excitable 
Membranes, by Bertil Hille). 
 
Ion channel glycosylation, sialic acid, and Nav 
     Ion channels are typically glycosylated when in their fully processed form.  
Protein glycosylation occurs inside the ER and Golgi complex.  Some protein 
glycosylation requires activated carbohydrates as precursors while other forms 
require oligosaccharide-pyrophosphoryldolichol.  Activated carbohydrates are 
ones that have reacted with UTP, CTP, or GTP, forming an XDP-carbohydrate 
derivative.  Once the reaction is complete, the activated sugar is transported 
across the ER membrane via a transporter that exchanges XTP for XDP-
carbohydrate.  Once inside, the carbohydrate is transferred to the growing 
glycoprotein chain by enzymes called glycosyl transferases.  Other sugars are 
transported into the ER by a carrier lipid (dolichol), which acts as an intermediate 
in the reaction, forming the oligosaccharide-pyrophosphoryldolichol complex.   
     The overall process of protein glycosylation can typically be broken down into 
two types, O-linked and N-linked glycosylation.  The amino acid side chains to 
which the carbohydrate group links defines each of the two types.  In the case of 
O-linked glycosylation, the sugars are attached to hydroxyl groups.  In the case 
 20 
 
of N-linked glycosylation, the sugars are attached to amino groups.  With O-
linked, either a single mannose or acetylgalactosamine residue is transferred 
from an ER nucleotide carrier to the hydroxyl side chain of a serine, threonine, 
hydroxyproline, or hydroxylysine amino acid.  The completion of the O-linked 
chain takes place in the Golgi complex with various sugars like 
acetylgalactosamine, galactose, fucose, and sialic acid.  To accomplish N-linked 
glycosylation, two acetylglucosamine and nine mannose are attached to the ER 
carrier lipid dolichol.  Once assembled the sugar complex is transferred to an 
asparagine residue that is followed by a serine or threonine.  Once attached, the 
protein is transferred to the Golgi where it becomes a high mannose, hybrid, or 
complex N-linked glycoprotein through the addition of N-acetylglucosamine, 
mannose, galactose, and or sialic acid (figure 8).   
     Voltage-gated Na+ channels contain complex N-linked glycosylation 
structures.  The defining characteristic of complex structures is that multiple sialic 
acid branches cap them.  Sialic acids are unique carbohydrates by virtue of the 
fact that, under normal physiological conditions, they are the only sugars that are 
charged, carrying a net -1 charge.  All of this added negative charge surrounding 
the voltage-gated channel may potentially exert an effect on channel gating.  Up 
to 35% of the total mass of many Nav may be attributed to carbohydrate (Cohen 
& Levitt, 1993;Gordon et al., 1988;Roberts & Barchi, 1987;Schmidt & Catterall, 
1987;Messner & Catterall, 1985).  Up to 45% of these carbohydrates may be 
composed of sialic acid residues, with around 100 or more sialic acid residues 
attached to each α-subunit (Roberts & Barchi, 1987).  Previous reports have  
 21 
 
Figure 8:  The three different types of known N-linked glycosylation structures 
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Figure 8:  (continued) 
 
Attached to asparagine residues, there are three different types of N-linked 
glycosylation structures that each shares the same base structure.  Segment A is 
high mannose N-linked glycosylation that terminates with multiple mannose 
residues.  Segment B is hybrid N-linked glycosylation terminating with a mixture 
of mannose and galactose residues.  Segment C is complex N-linked 
glycosylation terminating with multiple sialic acid residues. 
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indicated that sialic acid (SA) may play a role in channel function.  Nearly 
identical depolarizing shifts in Nav1.4 gating were observed using three 
independent methods to reduce channel sialylation as expressed in CHO cells.  
Chemical desialylation of the cardiac Nav α subunit (Nav1.5) expressed in HEK 
293 cells resulted in depolarizing shifts in the voltage of half-activation, Va, while 
a second study of Nav1.5 expressed in CHO cells reported no SA-dependent shift 
(Bennett, 2002;Zhang et al., 1999).  Because the effects of sialic acid on channel 
gating vary with the expression system used, studies of Nav function in 
cardiomyocytes would be the most direct means of addressing whether sialic 
acid alters cardiac sodium channel gating.   
 
The surface potential theory 
     The idea of a surface potential theory has been considered for around 50 
years.  The theory describes how fixed negative charges, at and around the ion 
channel associated membrane surface, serve to create a negative surface 
potential altering the electric field sensed by the channel voltage sensors.  This 
external negative surface potential acts to depolarize the membrane bringing the 
Nav closer to its threshold potential for activation, thus affecting gating.  The 
establishment of a surface potential can be derived by many factors like sialic 
acids, charged lipids making up the cell membrane, charged amino acids 
comprising proteins, and electrolytic screening in solution.  Changing [cation]o 
has been shown to screen a suspected negative surface potential affecting Na+, 
Ca2+, and K+ channel gating, with increasing concentrations causing channel 
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activation and inactivation to be shifted in the depolarized direction (Bennett et 
al., 1997;Hahin & Campbell, 1983;Campbell & Hille, 1976;Dorrscheidt-Kafer, 
1976;MOZHAYEV.GN & Naumov, 1970;BLAUSTEI.MP & Goldman, 1968;Hille, 
1968;Hagiwara & Naka, 1964;Frankenhaeuser & Hodgkin, 1957;Weidmann, 
1955).  This phenomenon can be considered the divalent screening effect.  This 
translates into the need for a greater depolarization to enact channel activation in 
the presence of elevated divalent cations levels.  Sialic acid, being negatively 
charged and so closely associated with the Nav, is an ideal candidate to be a 
strong contributor to a negative surface potential. 
 
The cardiac action potential and Nav 
     The cardiac action potential, the electrical signal that is spread across the 
atria and ventricles resulting in cardiac systole, is accomplished through the 
orchestrated opening and closing of voltage-gated sodium, potassium, and 
calcium channels.  The cardiac action potential (figure 9) consists of 5 phases 
starting with phase 0.  At phase 0 a propagating membrane depolarization from 
neighboring cells elicits the opening of fast current voltage-gated Nav allowing 
Na+ to rush into the myocyte, iNa, the membrane is depolarized to threshold and 
an action potential begins.  At the same time the Nav are activated, the rapid 
membrane depolarization causes inward rectifier K+ channels to close, iK1i, and 
then transient outward K+ channels open resulting in a brief membrane 
repolarization, iTO, known as phase 1.  Also at the start of phase 1, the Nav have 
now begun to move into the inactivated state ending their role in the action  
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Figure 9:  The cardiac action potential and current flow 
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Figure 9:  (continued) 
 
Panel A is an example of a cardiac action potential with the five distinct parts 
labeled from 0 - 4.  Panel B outlines the various ionic currents making up the five 
different parts of the action potential responsible for its shape and duration. 
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potential.  Phase 2 marks the plateau phase of the cardiac action potential.  The 
plateau phase results from the initial depolarization also causing the opening of 
Ca2+ channels, iCa, that first counteract the decreasing iTO current.  At the same 
time, delayed rectifier K+ channels are activated, iK, that counteracts the 
diminishing iCa after iTO stops bringing about the end of the plateau and the 
beginning of phase 3.  During phase 3 the remaining iK hyperpolarizes the cell 
enough the cause the inward rectifier K+ channels to reopen, iK1, completely 
repolarizing the cell back to its resting membrane potential maintained during 
phase 4.  The repolarization of the cell triggers the Nav from phase 0 to move 
from their inactivated to closed states.  Now the cell is ready to be refired once 
more. 
     The primary voltage-gated sodium channels found in cardiac atrial and 
ventricular myocytes, Nav1.5, are responsible for the initiation and propagation of 
action potentials resulting in cardiac systole (figure 7).  To date, expression of 
Nav1.1, Nav1.3 Nav1.5 and Nav1.6 have been reported to be expressed in cardiac 
tissue from animals such as rat, rabbit and mouse (Malhotra et al., 
2001;Baruscotti et al., 1997;Rogart et al., 1989).  However, research from mice 
has demonstrated that Nav1.5 appears to be the dominant current producing 
cardiac Nav involved in the cardiac action potential phase zero (Lei et al., 
2004;Maier et al., 2002;Zimmer et al., 2002).   
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Cardiac Nav gating in adult and neonatal cardiomyocytes 
     While Nav1.5 is the primary current carrying sodium channel expressed in the 
heart throughout development, previous studies suggested that there are 
differences between neonatal and adult cardiac ventricular Nav gating (Zhang et 
al., 1992).  This report showed a large hyperpolarizing shift in the voltage 
dependence of steady-state inactivation and an increase in the rate of 
inactivation through development.  It was speculated that the developmental 
effects on channel inactivation were attributed to differential sympathetic 
innervation.  Similar results for changing rate of Na+ channel inactivation were 
reported for chick embryo ventricle through development (Fujii et al., 1988). 
     Previous studies of cardiomyocytes have suggested that channel 
glycosylation may impact heart function.  In rabbit sino-atrial nodal cells and 
ventricular myocytes, it was shown that treatment with neuraminidase resulted in 
increased L and T-type Ca2+ current, suggesting that sialic acid is important in 
the maintenance of proper cardiac cell Ca2+ permeability (Marengo et al., 
1998;Fermini & Nathan, 1991).  Neuraminidase treatment of adult mouse 
ventricular myocytes altered the voltage dependence and conductance of 
transient outward K+  (Ito) and fast inward Na+ (INa) currents and reduced the 
number of rat cardiac M2 muscarinic agonist-receptor complexes (Ufret-Vincenty 
et al., 2001a;Ufret-Vincenty et al., 2001b;Haddad et al., 1990).  Perhaps some of 
the differences observed in cardiac Nav gating through development can be 
attributed to changing levels of channel glycosylation. 
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β interaction with α 
     In addition to the varying voltage-gated sodium channel α subunits that alone 
comprise functional pore forming ion channels, there also exists auxiliary β 
subunits often associated with α.  There are currently four different β subunits, 
and two splice variants, that have been identified to interact in one way or 
another with the varying Nav α subunits of excitable tissues (Qin et al., 2003;Yu 
et al., 2003;Kazen-Gillespie et al., 2000;Morgan et al., 2000;Isom et al., 
1995a;McClatchey et al., 1993;Isom et al., 1992).  The main function(s) of β in 
the body have yet to be fully understood but are thought to be any number of a 
range of possible functions.  In one study β1, β2, and β3 when co-transfected with 
Nav1.2 (brain) in HEK293, resulted in Va and Vi, voltage of half-inactivation, being 
shifted in the depolarized direction.  β3 was also shown to increase persistent 
sodium currents thought to increase the excitability of specific neuronal groups to 
all of their input by amplifying synaptic summation (Qu et al., 2001).  In contrast, 
when co-transfected with Nav1.3 in CHO cells, β1 and β3 shifted Vi in the 
hyperpolarized direction.  Also, they observed no effect with β2 transfection alone 
or in combination (Meadows et al., 2002a).  β1-/- mice have been used to study 
the abnormalities that occur in the absence of normal β1 expression.  It was 
noticed that the mice were ataxic with spontaneous seizures and altered levels of 
expressed Nav1.1 and Nav1.3 in the absence of β1 suggesting a basis for epilepsy.  
It was also suggested that β1, in these mice, was important in regulating Nav 
density and localization with an implied role in axo-glial communication at nodes 
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of Ranvier (Chen et al., 2004).  It has also been suggested that β1 and β2 are cell 
adhesion molecules that recruit ankyrin (Isom, 2001). 
     More specifically in the heart, Nav1.5 and various β subunits have also been 
shown to interact.  Using immunocytochemistry, Nav1.5, together with β1 and β2, 
have been visualized at the intercalated disks (Maier et al., 2004).  Another group 
believes that tyrosine phosphorylation of β1 regulates its localization to the 
intercalated disks (Malhotra et al., 2004).  In the developing mouse heart, β1 
mRNA levels were shown to increase at late embryonic and neonatal stages 
being maximal in the adult with protein again visualized in the intercalated disks 
(Dominguez et al., 2005).  The β1 subunit is made up of a single transmembrane 
spanning segment with an extracellular N-terminus (figure 10).  The extracellular 
portion of the protein contains four potential N-glycosylation sites and a single 
immunoglobulin-like fold (Isom et al., 1992).  In modulating Nav1.5 channel gating 
it is generally noted that β1 co-expressed with α in various expression systems 
causes a hyperpolarizing shift in the voltage dependence of channel activation 
and inactivation (Johnson et al., 2004;Meadows et al., 2002a;Meadows et al., 
2002b;Meadows et al., 2001;McCormick et al., 1999;McCormick et al., 
1998;Chen & Cannon, 1995;Isom et al., 1995b;McClatchey et al., 1993).  
However, β1 co-expression in HEK 293 cells, specifically, has resulted in 
depolarizing shifts in Nav inactivation gating (Cummins et al., 2001;Dhar et al., 
2001;Qu et al., 2001).  It is thought that at least three of the four N-linked 
glycosylation sites are glycosylated, and are potentially capped by sialic acids  
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Figure 10:  Voltage-gated sodium channel β1 auxiliary subunit 
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Figure 10:  (continued) 
 
The voltage-gated sodium channel β1 subunit is made up of a single membrane 
spanning alpha helix with four predicted potential N-linked glycosylation sites. 
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(Isom et al., 1992;Messner & Catterall, 1985).  Could these sialic acids attached 
to β1 be responsible for hyperpolarizing shifts observed in Nav1.5 gating? 
 
Nav channel disorders 
     Voltage-gated sodium channels are vital for the proper initiation and 
propagation of action potentials in the body.  To reiterate, under normal 
conditions, Nav experience three conformation changes that define its behavior.  
Under hyperpolarized conditions the channel is in its closed resting state.  
Membrane depolarization drives the channel into its open state allowing current 
flow.  Soon after opening and following membrane depolarization the channel 
moves into the inactivated state blocking current flow.  Then, following 
membrane repolarization, the channel moves back to its resting state.  When the 
inactivation state of the channel comes on too slowly or incompletely then the 
repolarizing phase of the action potential and the resting membrane potential 
itself are altered potentially leading to disorders.  In skeletal muscle, examples of 
Nav disorders are paramyotonia congenita and hyperkalemic periodic paralysis 
(Bouhours et al., 2005;Brancati et al., 2003;Lehmann-Horn et al., 
1987a;Lehmann-Horn et al., 1987b).  In the central nervous system Nav 
mutations have been implicated in epilepsies with a variety of phenotypes 
including generalized epilepsy with febrile seizures plus (GEFS +), severe 
myoclonic epilepsy in infancy (SMEI), intractable childhood epilepsy with 
generalized tonic-clonic seizures (ICEGTC), and benign familial neonatal-infantile 
seizures (BFNIS) (Nagao et al., 2005;Pineda-Trujillo et al., 2005;Yamakawa, 
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2005;Kanai et al., 2004).  In the heart Nav1.5 mutations have been implicated in 
diseases such as Brugada syndrome, long QT syndrome, dilated 
cardiomyopathy, arrhythmia, and conduction disorders (McNair et al., 
2004;Splawski et al., 2002;Bennett et al., 1995;Wang et al., 1995;Abriel et al., 
2001). 
     In addition to these disorders that are linked to various abnormalities 
associated with the channel protein there are also a host of disorders linked to 
irregularities in channel glycosylation.  These disorders affect both N and O-
linked glycosylation and are commonly referred to as congenital disorders of 
glycosylation, or CDGs.  There are twelve N-linked and four O-linked CDGs 
affecting a wide range of ion channels in the body.  Each of these CDGs are 
caused by protein abnormalities, mostly enzymes, due to specific gene defects.   
These many CDGs present themselves in a number of different phenotypes.  
The O-linked CDGs are involved in four different abnormalities known as Ehlers–
Danlos syndrome (connective tissue disorder), multiple exostoses syndrome 
(bone disorder of the epiphyseal plates), Walker–Warburg syndrome (lack of 
normal folds of the brain, malformations of the cerebellum, abnormalities of the 
retina, and progressive degeneration and weakness of the voluntary muscles), 
and muscle–eye–brain disease (muscle weakness and a flaw in neuronal 
migration resulting in a brain with a bumpy appearance and loss of  normal 
folding).  The twelve different N-linked CDGs are separated into two groups.  The 
first group is described by eight assembling defects, labeled CDG-Ia to CDG-Ih, 
and the second by four processing defects, labeled CDG-IIa to CDG-IId).  These 
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multiple CDGs in turn result in a number of defects such as hypotonia, failure to 
thrive, developmental delays, hepatopathy, coagulopathy, esotropia, seizures, 
cerebellar hypoplasia, ataxia, dysarthria, retinis pigmentosa, progressive scoliosis, 
joint contractures, and absence of puberty in females (Marklova & Albahri, 2004;Jaeken, 
2003;Marquardt & Denecke, 2003;Martin & Freeze, 2003;Grunewald et al., 2002). The 
most common test used to diagnose a CDG is isoelectric focusing of serum 
transferrin, which contains two N-linked glycosylation sites terminated with sialic 
acids.  When an abnormality is present, the protein is deficient in sialic acid, 
which changes its IEF signature.  Any of the CDGs that ultimately lead to Nav 
sialic acid glycosylation deficiencies may have a direct effect on cellular 
excitability. 
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Materials and Methods 
 
Construction of α and β cDNAs 
     The voltage gated cardiac sodium channel, Nav1.5, was kindly provided in 
vector pRC-CMV (Invitrogen) by Dr. A. L. George Jr.  The voltage gated sodium 
channel beta subunit, hβ1, was subcloned into the bicistronic vector, pIRES-
EGFP (Clontech), to provide use of visual inspection to ensure β1 expression. 
 
Pro5, Lec2 cell culture 
     Pro5 and Lec2 cells were grown in T25 flasks (Corning).  Pro5 growth 
medium consisted of αMEM (with ribo- and deoxyribonucleosides, Invitrogen) 
and 10% FBS.  Lec2 growth medium consisted of αMEM (without ribo- and 
deoxyribonucleosides) and 10% FBS (Mediatech).  Each growth medium also 
contained 100 µg / ml-1 streptomycin and 100 U / ml-1 penicillin.  Cells were 
passaged once every three to four days.  First, the growth medium was removed, 
the cells were then rinsed once with PBS (Mediatech), and then 0.5 ml of trypsin 
/ EDTA (0.05% / 0.53mM Mediatech) was added.  The cells incubated in the 
trypsin for about 30 seconds to 1 minute, then the flask was tapped to fully 
dislodge the cells from the flask.  To the 0.5 ml of trypsin was added 4.5 ml of the 
appropriate growth medium to stop the reaction.  Then, an appropriate volume of 
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this cell suspension was added to a new T25 flask with enough growth medium 
to equal 5 ml total. 
 
Pro5, Lec2 cell transfection 
     Pro5, and Lec2 cell transfections were accomplished as previously described 
(Johnson et al., 2004).  Briefly, cells were seeded onto 35 mm dishes 24 hr 
before use.  The transfection mixture consisted of 1 ml of Opti-mem, 8 µl 
lipofectamine (Invitrogen), and 2.0 – 2.5 µg DNA (90% hH1 α subunit vector and 
10% pGreen Lantern Fluorescent Protein (GFP; Invitrogen) or β1 subunit vector) 
in which the cells were incubated for 24 hr.  The transfection mixture was 
replaced with the appropriate growth media and the cells were then ready to use 
48 hr later. 
 
Pro5, Lec2 cell homogenization 
     Cells were first grown to confluence on 100 mm culture dishes.  The media 
was aspirated off and the cells were rinsed twice with ice cold PBS.  Then, each 
dish was incubated for five minutes with 1.5 ml of ice cold homogenization buffer 
(20 mM tetrasodium pyrophosphate, 20 mM Na2PO4, 1 mM MgCl2, 0.5 mM 
EDTA, 300 mM sucrose, 0.8 mM benzamidine, 1 mM iodacetamide, 1.1 µM 
leupeptin, 0.7 µM pepstatin, 76.8 nM aprotinin).  The cells were then scraped off 
and ground in a dounce tissue grinder (40 strokes).  The resulting suspension 
was centrifuged for 5 minutes at 3,200g at 4˚C.  The supernatant was then 
centrifuged for 1 hour at 100,000g at 4˚C.  The pellet was kept and then 
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resuspended in 100 µl of fresh homogenization buffer and stored at -80˚C for 
future use. 
 
Neonatal and adult rat cardiomyocyte isolation and culture 
     Cardiomyocytes were isolated from male neonatal (3-5 days) and adult (10 
week +) Sprague-dawley rats.  The neonatal cardiomyocyte isolation protocol 
was adapted from a method previously described (Isenberg & Klockner, 1982).  
Neonatal rats were anaesthetized with pentobarbital sodium (200mg/kg).  Atrial 
or ventricular tissue was dissected out and washed in 0 Ca2+ Tyrode solution and 
then separated into individual myocytes by immersion in 0.1% collagenase 
(Sigma type I) solution for 0.5 hours, centrifuged for 5 minutes @ 160 g, then 
retreated with fresh collagenase solution for 1 hour.  The tissue was then 
triturated to disperse the myocytes.  The myocyte rich collagenase solution was 
centrifuged @ 160 g for 5 minutes, rinsed with KB solution, centrifuged again, 
and then plated with culture media.  Adult ventricular and atrial myocytes were 
isolated using a Langendorf perfusion protocol (7-10 ml / minute) adapted from a 
method previously described (Saint et al., 1992).  The adult rats were 
anaesthetized with pentobarbital sodium (200mg/kg) and their hearts were then 
dissected out.  The whole hearts were first perfused with 0Ca2+ Tyrodes for five 
minutes, then with 300 units/ml collagenase (Sigma type I) and 7 mg protease 
(Sigma type XIV) in 0Ca2+ Tyrodes for 12 minutes, followed by 5 minutes of 
perfusion with 0.1mmol/L Ca2+ Tyrodes.  Atrial and ventricular tissue was then 
cut down and triturated in 0.1mmol/L Ca2+ Tyrodes, run through a 200 µm filter, 
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rinsed 3 times with culture media, and then plated.  The growth media consisted 
of DMEM (Mediatech) supplemented with 25 mM Hepes, 15% FBS, and 100 µg / 
ml-1 streptomycin and 100 U / ml-1 penicillin.   
 
Neonatal rat ventricular myocyte transfection 
     Neonatal rat ventricular myocytes were isolated and seeded onto 35 mm 
dishes as previously described.  The transfection mixture consisted of 6 µl 
effectine (Qiagen) with 2 µg β1 subunit vector.  The transfection mixture was then 
added to a fresh 1 ml of growth media 3 hours after the cells were isolated.  The 
cells were then used for electrophysiology within 48 hr.   
 
Cardiac tissue homogenization 
     First, the appropriate cardiac tissue was dissected out (atrial or ventricular), 
rinsed of blood in ice cold PBS and placed into a 50 ml conical tube with 4 ml of 
ice cold homogenization buffer.  Using a Polytron homogenizer (Brinkmann 
Instruments model #PT10/35) set at 10, the tissue was pulsed several times to 
ensure complete homogenization.  The homogenate was then stored at -80˚C for 
future use. 
 
Electrophysiology 
     Cells were studied using the patch clamp whole cell recording technique 
previously described (Bennett, 2002;Bennett et al., 1997).  Briefly, an Axon 
Instruments 200B patch-clamp amplifier with a CV203BU headstage (Axon 
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Instruments) was used in combination with a Nikon TE200 inverted microscope.  
The pulse protocols were generated using a Pentium II computer (Dell 
Computers) running pulse acquisition software (HEKA).  The resulting analog 
signals were filtered at 5 kHz using an eight-pole Bessel filter (9200 LPF; 
Frequency Devices) and then digitized using the ITC-16 AD/DA converter 
(Instrutech).  A micromanipulator (MP-285 Sutter, Novato, CA, USA) was used to 
place the electrode on the cell.  Electrode glass (Drummond capillary tubes) was 
pulled using a Sutter (model P-87) electrode puller to resistances of 1-2 MΩ. 
 
Measuring Pro5, Lec2 Na+ currents 
     The external recording solution used consisted of: (in mmol/L) 224 sucrose, 
22.5 NaCl (ph with NaOH), 4 KCl, 2.0 CaCl2, 5 glucose, and 5 Hepes.  The 
internal recording solution consisted of: (in mmol/L) 120 sucrose, 60 CsF, 32.5 
NaCl (ph with NaOH), and 5 Hepes.  All data was collected between 5-10 
minutes after achieving whole cell configuration ensuring complete dialysis. 
     Series resistance was compensated from 95 - 98% for all the data.  
Additionally, the smaller current produced by using the low sodium solutions 
further minimized any remaining series resistance error, resulting in a <1 mV 
error.  Immediately prior to use, each solution was filtered using a 0.2 µm 
Gelman filter.  All experiments were performed at room temperature (~22oC).   
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Measuring whole myocyte Na+ currents 
     The whole cell recording extracellular solution was: (in mmol/L) 5 NaCl, 10 
TES, 5 KCl, 1 CaCl2, 5 CsCl, 10 glucose, 115 choline chloride.  The electrode 
solution consisted of (in mmol/L) 120 CsF, 10 TES, 2 MgCl2, 2 CaCl2, 5 NaCl, 20 
EGTA.  Both the ECF and ICF contained 20 NaCl for the neonatal myocyte ionic 
strength experiments. 
     To ensure proper space clamping of the cardiomyocyte, several measures 
were taken: 1) Data were analyzed from cells producing sodium currents of 7nA 
or less, and reversing at the predicted sodium reversal potential.  This required 
solutions containing only 5 mM NaCl (adult cells cannot be clamped at 20 NaCl).  
2) Only myocytes of 76 pF or less were analyzed, to ensure greater ease of 
space clamp.  3) The slope of the G-V Boltzmann relationships were monitored, 
and only cells in which the slope > 5 mV were analyzed.  Any steeper slope 
indicated a loss of voltage clamp.  4) All analyzed data were collected between 8-
12 minutes after achieving whole cell configuration. 
     In addition to these precautions, all data were series resistance compensated 
to 95 - 98%.  If proper compensation was not achieved, the data were not 
analyzed.  Immediately prior to use, each solution was filtered using a 0.2 µm 
Gelman filter.  All experiments were performed at room temperature (~22oC).   
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Pulse protocols for measuring whole cell Na+ currents 
     Pulse protocols were performed as described previously in Bennett, 2002 
except that the holding potential used here was -120 mV (rat) and -100 (Pro5, 
Lec2).  Brief descriptions of the protocols follow. 
Conductance-voltage (G-V) relationship 
     Cells were stepped for 10 ms from their respected holding potentials to 
various depolarized potentials, ranging from -100 mV to +40 (rat) and +70 mV 
(Pro5, Lec2) in 10 mV increments.  Consecutive pulses were stepped every 1.5 
seconds and the data were leak subtracted using the P/4 method, stepping 
negatively from the -120 mV holding potential.  At each test potential, steady-
state whole cell conductance was determined by measuring the peak current at 
that potential and dividing by the driving force (i.e., difference between the 
membrane potential and the observed reversal potential).  Peak conductance as 
a function of membrane potential was plotted.  The maximum sodium 
conductance for a single cell was determined by fitting the data to a single 
Boltzmann distribution (equation 1, solving for maximum conductance). The 
average Va ± SEM and Ka ± SEM values were determined from these single 
Boltzmann distributions.  The normalized data were then averaged with those 
from other cells, and the resultant average conductance-voltage curve was fit via 
least squares using the following Boltzmann relation:   
 Fraction of maximal conductance = [1+(exp-(V-Va/Ka))]-1, equation (1)  
where V is the membrane potential, Va is the voltage of half activation, and Ka is 
the slope factor.   
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Steady-state inactivation curves (hinf) 
     Cells were first prepulsed for 500 ms from their respected holding potentials to 
the plotted potentials ranging from -130 mV to -20 mV (rat) and +10 mV (Pro5, 
Lec2) in 10 mV increments, then to +40 mV for 5 ms, then back to the -120 mV 
holding potential.  Currents from each cell were normalized to the maximum 
current measured by fitting the data from a single cell to a single Boltzmann 
distribution (equation 2, solving for maximum current), from which the mean Vi  
+/- SEM and Ki +/- SEM values were determined.  The normalized data for many 
cells were then averaged and fit to equation (2), from which the mean voltage of 
half inactivation (Vi) and slope factor (Ki) parameters for each cell type describing 
steady-state inactivation for the channel population were calculated. 
Fraction of maximum current = [1+(exp((V-Vi)/Ki))]-1  equation (2) 
Measurement of inactivation time constants (τh) 
     Inactivation time constants for each cell type were determined by fitting to 
single exponential functions the attenuating portions (90% - 10%) of the current 
traces used to measure the G-V relationships. 
Recovery from inactivation 
     Cells were held at their respected holding potentials, pulsed to +40 mV (rat) or 
+60 mV (Pro5, Lec2) for 10 ms, and then stepped to the recovery potential for 1 
to 20 ms in 1 ms increments.  Following the recovery pulse, the potential was 
again stepped to +40, or +60 mV for 10 ms.  The peak currents measured during 
the two +40, or +60 mV depolarizations were compared to determine the 
fractional current measured during the second pulse.   
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Desialylation of rat cardiomyocyte sodium channels  
     For desialylation experiments, cells plated onto 35 mm dishes were exposed 
to 1.125 - 1.500 units neuraminidase (Sigma type X) / 1 ml DMEM for 3 hours.  
Immediately following treatment, cells were rinsed with and allowed to recover in 
their appropriate growth media at 3 - 5˚C for 0.5 hours to wash out enzyme and 
quench further enzymatic reactions.   
 
Deglycosylation of rat cardiomyocyte sodium channels 
     For deglycosylation experiments, cells plated onto 35 mm dishes were 
exposed to 19 - 20 units PNGase-F (Sigma) / 1 ml DMEM for 12 hours.  
Immediately following treatment, cells were rinsed with and allowed to 
recover in their appropriate growth media at 3 - 5˚C for 0.5 hours to wash 
out enzyme and quench further enzymatic reactions.   
 
Antibody production and purification  
     α1Ab was produced as previously described (Bennett, 1999).  Site-directed 
polyclonal antibodies (α1Abs) were raised to an 18-mer peptide (pep-α1; 
α Diagnostics) corresponding to the highly conserved III-IV linker region 
(TEEQKKYYNAMKKLGSKK) in vertebrate sodium channels and were affinity-
purified on a pep-α1-coupled column.  β1Abs were raised to a 20-mer peptide, 
GCLAITSESKENCTGVQVAE.  Antibody concentrations were assayed using 
optical density (O.D.) measurements at a 280-nm wavelength, with the accepted 
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estimate that a 1.0 O.D. reading approximates 0.8 mg / ml α1Ab (Harlow & Lane, 
1988).  
 
Immunoblots 
     Cardiomyocyte homogenates were made by first harvesting the appropriate 
tissues (neonatal and adult cardiac atrial/ventricular muscle).  The tissue was 
placed in ice cold sodium pyrophosphate buffer containing protease inhibitors 
inhibitors (in mmol/L):  20 tetrasodium pyrophosphate, 20 Na2PO4, 1 MgCl2, 0.5 
EDTA, 300 sucrose, 0.8 benzamidine, 1 iodacetamide, 1.1 leupeptin, and 0.7 µM 
pepstatin and 76.8 nM aprotinin, and homogenized using a Polytron 
homogenizer (Brinkmann Instruments model #PT10/35), set at 10, pulsed 
several times to ensure complete homogenization, and then stored at -80˚C.    α 
and β1 samples were mixed with sample buffer (10% glycerol, 5% 2-
mercaptoethanol, 3% SDS, 12.5% upper Tris buffer), denatured for 2 minutes in 
boiled water, and then loaded into the lanes of a minigel cast from 4.5% 
acrylamide.  The gel was run for its full length at 75 - 100 V and then 
electrophoretically transferred to nitrocellulose paper using a semi-dry transfer 
cell (Biorad) for 22 minutes at 8 - 14 V.  Cardiac sodium channel α and β1-
subunits were detected using a site-directed polyclonal antibody previously 
described (α1Ab, β1Ab), (Bennett, 1999) then incubated with donkey anti-rabbit 
horseradish peroxidase conjugated secondary antibody (Amersham) for 2 hours, 
and visualized using a Pierce enhanced chemiluminescence kit.  Immunoblot gel 
shift analysis of the α-subunit under conditions of full and reduced sialylation 
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were done by incubating homogenates with 1.35 units neuraminidase / 10 µg 
protein for 3 hours at 37˚C.  Complete deglycosylation was accomplished via 
treatment with 20 units PNGase-F (Sigma) / 10 µg protein for 12 hours at 37˚C. 
 
Data analysis 
     All electrophysiological data were analyzed using Pulse / PulseFit (HEKA) and 
Sigmaplot 2001 (SSPS Inc.) software.  Sigmagel (SSPS Inc.) software was used 
to quantify the immunoblot data. 
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Results 
 
The ventricular Nav of the newborn gates at more depolarized potentials  
     The first step in attempting to determine the effects of channel sialylation / 
glycosylation on gating is to collect control data.  Whole cell currents similar to 
that shown in Figure 11A were recorded from primary cultures of neonatal and 
adult ventricular and atrial myocytes.  Biophysical analyses of the sodium 
currents revealed that neonatal and adult atrial and adult ventricular Nav gate 
following smaller depolarizations than do neonatal ventricular Nav.  Figures 11A 
and B plot the steady-state activation (11A) and inactivation (11B) of the neonatal 
and adult channels as a function of membrane potential.  Both the Va and Vi for 
the adult ventricle are 9 - 10 mV more hyperpolarized than those measured for 
the neonatal ventricular channels.  In addition, the Va and Vi for the atrial Nav are 
similar to the adult ventricular Nav parameters (11A, B).  Figure 11C shows the 
fast inactivation time constants (τh) for each.  Note that for the neonatal 
ventricular Na+ current, τh generally is slower than for any of the other Nav.  The 
time to Nav recovery from fast inactivation, τrec, for all four samples is displayed in 
figure 11D.  τrec is slower for all atrial and adult ventricular Nav compared to the 
neonatal ventricular Nav (11D).  Collectively, these data reveal a consistent 
chamber-specific difference in neonatal cardiac Nav voltage dependent gating, 
and a developmental hyperpolarization in Nav gating in the ventricle.   
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Figure 11:  Whole cell recordings of isolated adult and neonatal atrial and 
ventricular myocytes - determining voltage-dependent Nav gating characteristics 
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Figure 11:  (continued) 
 
Circles:  neonatal VCM.  Squares:  adult VCM. Triangles:  neonatal ACM.  
Inverted Triangles:  adult ACM.  Panel A:  Steady-state activation (G-V 
relationships).  Inset:  Whole cell Na+ current from an isolated adult VCM.  
Currents were measured during test pulses of -100 to +40 mV in 10 mV 
increments from the -120 mV holding potential. Panel B:  Steady-state 
inactivation (hinf).  Data are the average peak current ± S.E.M. measured during 
a 5 msec pulse to +40 mV following a 500 msec prepulse to the plotted 
potentials.  Inset:  Whole cell Na+ currents measured during a series of +40 mV 
test pulses, each following a prepulse to a larger depolarization ranging from  
-130 mV to -20 mV in 10 mV increments. 
panel C:  Time constant of fast inactivation (τh). Data are the average τh ± 
S.E.M. Curves are non-theoretical point-to-point.  Inset:  Current traces during a -
50 mV test pulse.  Solid traces:  neonatal and adult ACM and adult VCM (NA, 
AA, and AV, respectively).  Dotted trace:  neonatal VCM (NV).  
Panel D:  Voltage dependence of the recovery time constants (τrec).  Data are 
the average τrec ± S.E.M.   Lines are non-theoretical point-to-point.  Inset:  
Plotted recovery data for all four conditions at a -130 mV recovery potential.  
Curves are fits of the data to single exponential functions.  Solid curves:  NA, AA, 
and AV.  Dotted curve:  NV. 
For these and all remaining figures: NA (up arrows), AA (down arrows), NV 
(circles), AV (squares). 
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Gating of three of the four Nav types are sensitive to desialylation – only the 
neonatal VCM Nav are insensitive 
     To determine whether the observed chamber-specific and developmental 
shifts in Nav gating can be attributed to differences in functional channel sialic 
acids, cells were desialylated by treatment with neuraminidase.  Figure 12B 
shows that, following neuraminidase treatment, the neonatal atrial channels are 
sensitive to desialylation, with the Va shifting by 7 mV to more depolarized 
potentials following neuraminidase treatment.  However, identical treatment of 
the neonatal ventricular Nav had no effect on Nav Va (12A).  Desialylation of both 
the adult atrial and ventricular Nav resulted in similar depolarizing shifts in Va 
indicating a lack of adult chamber differences in contrast to that seen in neonate 
(fig. 13).  When studied from a developmental point of view, neuraminidase 
treatment of adult ventricular Nav caused a significant 10 mV depolarizing shift in 
Va (fig. 14B) when compared to the sialic acid insensitive neonatal ventricular Nav 
Va (14A).  Figure 15A and B show that both the neonatal and adult atrial 
channels are sensitive to desialylation, with both Va shifting by approximately 7 
mV to more depolarized potentials following neuraminidase treatment. 
     Desialylation similarly alters steady-state channel inactivation in a chamber-
specific and developmentally dependent manner.  Figure 16B shows a significant 
5 mV depolarizing shift in neonatal atrial Nav Vi following desialylation, while 
neonatal ventricular Nav Vi remains unaffected by treatment (16A).  Desialylation 
of both the adult atrial and ventricular Nav resulted in similar depolarizing shifts of 
Vi demonstrating a lack of adult chamber differences in contrast to that seen in 
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Figure 12:  Desialylation of neonatal VCM and neonatal ACM Nav causes a 
depolarizing shift in ACM steady-state Nav activation.  Neonatal ventricular 
channels are unaffected 
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Figure 12:  (continued) 
 
G-V relationship for cardiomyocyte Nav ± neuraminidase.  Data are the average 
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Circles: neonatal VCM (A).  
Triangles: neonatal ACM (B). 
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Figure 13:  Desialylation of adult VCM and adult ACM Nav causes a depolarizing 
shift in steady-state Nav activation - both VCM and ACM channels are similarly 
affected 
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Figure 13:  (continued) 
 
G-V relationship for cardiomyocyte Nav ± neuraminidase.  Data are the average 
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Squares: Adult VCM (A).  
Inverted triangles: Adult ACM (B). 
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Figure 14:  Desialylation of neonatal VCM and adult VCM Nav causes a 
depolarizing shift in adult steady-state Nav activation - neonatal ventricular 
channels are unaffected 
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Figure 14:  (continued) 
 
G-V relationship for cardiomyocyte Nav ± neuraminidase.  Data are the average 
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Circles: neonatal VCM (A).  
Squares: adult VCM (B). 
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Figure 15:  Desialylation of neonatal ACM and adult ACM Nav causes a 
depolarizing shift in steady-state Nav activation - both neonatal and adult ACM 
channels are similarly affected 
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Figure 15:  (continued) 
 
G-V relationship for cardiomyocyte Nav ± neuraminidase.  Data are the average 
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Triangles: neonatal ACM (A).  
Inverted triangles: Adult ACM (B). 
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Figure 16:  Desialylation shifts steady-state inactivation curves for neonatal atrial 
Nav but has no effect on neonatal ventricular Nav inactivation 
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Figure 16:  (continued) 
 
Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase.  Data are the 
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to 
+40 mV following a 500 msec prepulse to the plotted potentials.  Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Circles: neonatal VCM (A).  
Triangles: neonatal ACM (B). 
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neonate (fig. 17).  When developmentally studied, the Vi for adult ventricular Nav 
is shifted by a depolarizing 13 mV with neuraminidase treatment (fig. 18B), 
compared to the insensitive neonatal VCM Nav (18A).  Figure 19A and B show 
that desialylation results in similar depolarizing shifts on neonatal and adult atrial 
Nav Vi, indicating no developmental shift in atrial Nav gating, in contrast to the 
ventricle.  The mean ± SEM values for all measured voltage dependent gating 
parameters are listed in Table 1. 
 
Sialic acids are responsible for faster inactivation kinetics - only neonatal 
ventricular Nav inactivation shows no sialic acid sensitivity 
     As shown in Figure 11C above, data indicate that atrial and adult ventricular 
Nav inactivate faster than neonatal ventricular Nav.  When comparing neonatal 
cardiac chambers, figure 20 shows a slowing of the rate of Nav fast inactivation 
for neuraminidase treated neonatal atria and the neonatal ventricular Nav, again 
showing no change with treatment.  Neonatal ventricular Nav remain insensitive 
to desialylation.  Following neuraminidase treatment of the adult cardiac 
chambers, desialylation resulted in comparable effects on Nav τh kinetics, unlike 
in the neonate (fig. 21).  When comparing the same chambers at two different 
ages, desialylation of the ventricles indicates a developmental shift in Nav τh sialic 
acid sensitivity (fig. 22).  Desialylation of the atria reveals essentially no 
developmental shift in Nav τh (fig. 23).  
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Figure 17:  Desialylation similarly shifts steady-state inactivation curves for both 
adult ventricular and adult atrial Nav 
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Figure 17:  (continued) 
Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase.  Data are the 
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to 
+40 mV following a 500 msec prepulse to the plotted potentials.  Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Squares: adult VCM (A).  
Inverted triangles: adult ACM (B). 
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Figure 18:  Desialylation shifts steady-state inactivation curves for adult 
ventricular Nav but has no effect on neonatal ventricular Nav inactivation 
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Figure 18:  (continued) 
Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase.  Data are the 
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to 
+40 mV following a 500 msec prepulse to the plotted potentials.  Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Circles: neonatal VCM (A).  
Squares: adult VCM (B). 
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Figure 19:  Desialylation similarly shifts steady-state inactivation curves for both 
neonatal and adult atrial Nav 
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Figure 19:  (continued) 
Channel availability (hinf) for cardiomyocyte Nav ± neuraminidase.  Data are the 
average normalized peak current ± S.E.M. measured during a 5 ms test pulse to 
+40 mV following a 500 msec prepulse to the plotted potentials.  Curves are fits 
of the data to single Boltzmann distributions.   
Filled symbols: untreated.  Open symbols: treated.  Triangles: neonatal ACM (A).  
Inverted triangles: adult ACM (B). 
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Figure 20:  Sialic acid increases the rate of fast inactivation for neonatal atrial 
Nav but has little effect on neonatal ventricular Nav inactivation rates 
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Figure 20:  (continued) 
 
Time constant of fast inactivation (τh) as a function of membrane potential for 
cardiomyocyte Nav ± neuraminidase.  Data are the average τh ± S.E.M. Curves 
are non-theoretical, point-to-point.  Filled symbols: untreated.  Open symbols: 
treated.  Circles: neonatal VCM (A).  Triangles: neonatal ACM (B).  
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Figure 21:  Sialic acid causes an increase in the rate of fast inactivation for both 
adult ventricular and adult atrial Nav 
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Figure 21:  (continued) 
Time constant of fast inactivation (τh) as a function of membrane potential for 
cardiomyocyte Nav ± neuraminidase.  Data are the average τh ± S.E.M. Curves 
are non-theoretical, point-to-point.  Filled symbols: untreated.  Open symbols: 
treated.  Squares: adult VCM (A).  Inverted Triangles: adult ACM (B). 
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Figure 22:  Sialic acid increases the rate of fast inactivation for adult ventricular 
Nav but has little effect on neonatal ventricular Nav inactivation rates 
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Figure 22:  (continued) 
 
Time constant of fast inactivation (τh) as a function of membrane potential for 
cardiomyocyte Nav ± neuraminidase.  Data are the average τh ± S.E.M. Curves 
are non-theoretical, point-to-point.  Filled symbols: untreated.  Open symbols: 
treated.  Circles: neonatal VCM (A).  Squares: adult VCM (B). 
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Figure 23:  Sialic acid causes an increase in the rate of fast inactivation for both 
neonatal atrial and adult atrial Nav 
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Figure 23:  (continued) 
Time constant of fast inactivation (τh) as a function of membrane potential for 
cardiomyocyte Nav ± neuraminidase.  Data are the average τh ± S.E.M. Curves 
are non-theoretical, point-to-point.  Filled symbols: untreated.  Open symbols: 
treated.  Triangles: neonatal ACM (A).  Inverted Triangles: adult ACM (B). 
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Sialic acids act to slow the rate of recovery from fast inactivation for all but 
the neonatal ventricular Nav 
     In line with the previously observed chamber-specific effects of Nav channel 
sialylation on neonatal gating, figure 24B shows that neonatal atrial Nav τrec is 
once more sensitive to neuraminidase treatment, the ventricular Nav are not (fig. 
24A).  Upon comparison of treated and untreated adult cardiac chambers, it is 
noted that again the adult atrial and ventricular Nav τrec share similar sensitivities 
to sialic acid, both becoming faster with treatment (fig. 25).  It also seems 
apparent that a developmental shift in channel sialylation also affects channel 
τrec.  When treated with neuraminidase the neonatal VCM Nav τrec was 
consistently unaffected while the slower adult τrec became significantly faster and 
more neonatal like (fig. 26).  Furthermore, figure 27 demonstrates for a fourth 
time a lack of a developmental shift in sialic acid sensitivity with respect to τrec 
when moving from the neonatal to the adult atria, as witnessed with the 
ventricles.  Following desialylation, recovery time decreases for all but the 
neonatal ventricular Nav.   
 
PNGase-F treatment, removing N-linked glycosylation, results in no 
significant difference in gating among all four tested Nav 
     Desialylation of the atrial and adult ventricular Nav via the use of 
neuraminidase has consistently accounted for the vast majority of the differences 
observed in atrial and adult ventricular Nav gating compared to the neonatal  
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Figure 24:  Recovery from fast inactivation for neonatal atrial Nav is faster 
following desialylation - neonatal ventricular recovery rate is unaffected by sialic 
acids 
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Figure 24:  (continued) 
 
Voltage dependence of the inactivation recovery times for cardiomyocyte Nav ± 
neuraminidase treatment.  Data are the measured τrec as a function of recovery 
potential.  Lines are non-theoretical point-to-point.   
Filled symbols: untreated.  Open symbols: treated.  Circles: neonatal VCM (A).  
Triangles: neonatal ACM (B). 
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Figure 25:  Recovery from fast inactivation for adult ventricular and adult atrial 
Nav are both faster following desialylation 
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Figure 25:  (continued) 
 
Voltage dependence of the inactivation recovery times for cardiomyocyte Nav ± 
neuraminidase treatment.  Data are the measured τrec as a function of recovery 
potential.  Lines are non-theoretical point-to-point.   
Filled symbols: untreated.  Open symbols: treated.  Squares: adult VCM (A).  
Inverted Triangles: adult ACM (B). 
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Figure 26:  Recovery from fast inactivation for adult ventricular Nav is faster 
following desialylation - neonatal ventricular recovery rate is unaffected by sialic 
acids 
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Figure 26:  (continued) 
Voltage dependence of the inactivation recovery times for ventricular 
cardiomyocyte Nav ± neuraminidase treatment.  Data are the measured τrec as a 
function of recovery potential.  Lines are non-theoretical point-to-point.   
Filled symbols: untreated.  Open symbols: treated.  Circles: neonatal VCM (A).  
Squares: adult VCM (B). 
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Figure 27:  Recovery from fast inactivation for neonatal atrial and adult atrial Nav 
are both faster following desialylation 
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Figure 27:  (continued) 
 
Voltage dependence of the inactivation recovery times for atrial cardiomyocyte 
Nav ± neuraminidase treatment.  Data are the measured τrec as a function of 
recovery potential.  Lines are non-theoretical point-to-point.   
Filled symbols: untreated.  Open symbols: treated.  Triangles: neonatal ACM (A).  
Inverted Triangles: adult ACM (B). 
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ventricular Nav.  The reason for these differences may be due to the possibility 
that likely more than just α subunit sialylation alone may be impacting channel 
gating.  A second, and simpler explanation may be due in part to inconsistent 
desialylation of the Nav from sample to sample, experiment to experiment.  
PNGase-F treatment of cardiac myocyte surface expressed Nav was employed to 
remove sialic acids, and the remaining N-linked sugar structures, as a second 
method to try and account for the remaining differences in gating seen after 
neuraminidase treatment.  Figure 28 provides a very clear and to the point 
comparison of the tested PNGase-F treated atrial and adult ventricular Nav gating 
parameters with that of the untreated and neuraminidase treated neonatal Nav 
(no difference observed with PNGase-F treatment for neonatal VCM (curves not 
shown)).  When studying steady-state activation and inactivation it can be noted 
that deglycosylation resulted in no differences between the atrial and adult 
ventricular Nav Va and Vi compared to control and desialylated neonatal VCM 
(figure 28A, B, Table 1).  PNGase-F treatment of the atrial and adult ventricular 
Nav also caused τh for these samples to slow to values insignificantly different to 
those of the control and desialylated neonatal VCM (figure 28C).  Additionally, 
τrec for the deglycosylated atrial and adult ventricular Nav became significantly 
faster, again resulting in virtually identical data for all four samples (figure 28D).  
In conclusion, these data strongly support the idea that the majority of observed 
differences between control atrial and adult ventricular Nav, compared to that of 
control neonatal VCM, could be attributed to differences in channel sialylation, 
with channel deglycosylation accounting for the remainder. 
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Figure 28:  Deglycosylation of atrial and adult ventricular Nav results in gating 
characteristics nearly identically to those of neonatal ventricular Nav 
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Figure 28:  (continued) 
Panel A: steady-state activation.  Panel B: steady-state inactivation.  Panel C: 
fast inactivation kinetics.  Panel D: recovery from fast inactivation kinetics.   All of 
the data shown for adult ACM/VCM and neonatal ACM Nav is following treatment 
with PNGase-F (open symbols), and the neonatal VCM Nav is under control 
(solid circles) and neuraminidase treated (dotted, open circles) conditions. 
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The atrial and adult ventricular Nav α subunit is apparently more heavily 
sialylated than the neonatal ventricular Nav 
     Figures 12 - 28 indicate that gating of the atrial and adult ventricular Nav are 
more sensitive to desialylation than is neonatal ventricular Nav gating.  One 
possibility is that the neonatal ventricular Nav is the least sialylated of the 
channels, with differential sialylation occurring throughout the developing 
ventricle and between the newborn’s atria and ventricle.  To test this possibility, a 
series of immunoblots were run to measure the apparent molecular weight (Mr) of 
Nav α subunits as expressed in the four cardiomyocyte types.  Homogenates of 
atria and ventricles harvested from newborn and adult rats were run on 4.5 % 
SDS-PAGE gels, blotted, and challenged with the α subunit Nav antibody, α1Ab.  
From these blots, it was apparent that the atrial and adult ventricular Nav α 
subunits were similar in Mr, and were consistently heavier than the neonatal 
ventricular channel (Figure 29A).  The average measured Mr for the atrial and 
adult ventricular α subunit was 251.8 +/- 0.6 kD (n=41), while the average Mr for 
the neonatal ventricular α subunit measured 246.5 +/- 0.8 (n=19).  Thus, the 
atrial and adult ventricular Nav α subunits were about 5 kD larger on average 
than the neonatal ventricular Nav α subunit.  Because the Mr observed for all four 
homogenates is significantly greater than the predicted Mr for unprocessed 
Nav1.5, (about 227 kD), the data indicate that all four channel types are 
glycosylated, with the neonatal ventricular channel less processed than the other 
three channel types.   
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Figure 29:  Gel shift analyses indicate that channel sialylation increases 
throughout the developing ventricle and is greater in the atria versus ventricle of 
the newborn 
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Figure 29:  (continued) 
 
Bands detected using αAb at a 1:200 concentration.  Lane labels: NV: neonatal 
ventricle.  AV: adult ventricle.  NA: neonatal atria.  AA: adult atria. 
Panel A:  Immunoblot of ACM and VCM at two developmental stages.  Lanes 1, 
4, and 7: Molecular weight markers.  5µg protein loaded per lane. 
Panel B:  Immunoblot of ACM and VCM ± PNGase-F treatment.  Lanes 1, 6, and 
11:  Molecular weight markers.  5µg protein loaded per untreated lane, 10µg 
protein loaded per treated lane.   
Panel C:  Immunoblot of ACM and VCM ± neuraminidase treatment.  Lanes 1, 6, 
and 11:  Molecular weight markers.  5µg protein loaded per untreated lane, 10µg 
protein loaded per treated lane.   
Panel D:  Bar graph of average measured Nav α subunit Mr for each 
homogenate ± PNGase-F ± neuraminidase.  Each bar represents the mean Mr ± 
SEM measured for a series of immunoblots.  Dark bars:  Untreated.  Light bars:  
PNGase-F treated.  Gray bars:  Neuraminidase treated.  SA: Sialic acid.  The  
number of samples measured is listed at the base of each bar.  Significance was 
determined for the untreated data using a two-tailed student’s t-test comparing 
the atrial and adult ventricular α subunit Mr to the neonatal ventricular α subunit 
Mr.  ** = Highly significant (P < 0.01)  
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     To determine more directly whether changes in channel glycosylation are 
responsible for the observed differences in Mr, myocyte homogenates were 
treated with the enzyme, PNGase-F.  PNGase-F removes N-linked glycosylation 
at the site of protein attachment.  In figure 29B, Mr for all four PNGase-F treated 
homogenates was reduced to 231.1 ± 0.9 kD (n=20), with no significant 
difference in Mr measured among the homogenates following PNGase-F 
treatment.  Thus, these data strongly indicate that the neonatal ventricular Nav is 
~5 kD less N-glycosylated than the other channel types tested. 
     To examine whether the differences in glycosylation levels observed are due 
to increases in α subunit sialylation, myocyte homogenates were treated with 
neuraminidase to remove sialic acids specifically.  As shown in Figure 29C, the 
measured Mr for all homogenates was reduced following neuraminidase 
treatment, suggesting that all cardiac Nav types are sialylated.  Consistently, the 
predicted α subunit Mr for all four homogenates were reduced to similar levels 
following neuraminidase treatment, indicating that the atrial and adult ventricular 
channels are more sialylated than the neonatal ventricular channel.  Figure 29D 
illustrates the average Mr measured for each Nav under control, PNGase-F, and 
neuraminidase treated conditions (listed in Table 2).  The graph shows that the 
untreated Mr for the atrial and adult ventricular channels are nearly identical, 
while the Mr for the untreated neonatal α subunit is significantly lower.  PNGase-
F and neuraminidase treatment results in a similar Mr for all four channel types, 
indicating that a difference in channel sialylation is primarily responsible for the 
differences in Nav Mr observed.  On average, the sialic acid dependent Mr 
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(change in Mr with neuraminidase treatment) for the neonatal ventricular Nav α 
subunit is about 5.3 kD, while the average SA-dependent Mr for the other three 
channel α subunits is a much larger, 9.1 kD.  Direct comparison of the SA-
dependent shift in Mr for neonatal VCM versus the other three channel types 
produced a highly significant, 3.8 +/- 0.4 kD difference (n=23), all of which can be 
assigned to channel sialic acids.  This 3.8 kD of sialic acids (a 72 % increase 
from neonatal VCM to ACM and adult VCM) added throughout the developing 
ventricle and between chambers of the newborn heart is consistent with about 15 
more sialic acid residues attached to the atrial and adult ventricular Nav α 
subunits.  
 
Increased functional sialylation of atrial and adult ventricular Nav account 
for most of the hyperpolarizing shifts in channel gating 
     The immunoblot gel shift analyses shown above indicate that the neonatal 
ventricular Nav α subunit is the least sialylated among the four tested 
cardiomyocyte α subunits.  As shown in Figures 11-28, the neonatal ventricular 
channel consistently gates following larger depolarizations compared to the 
voltage dependent gating of the other channel types.   Further, gating of the atrial 
and adult ventricular Nav all shifted to more depolarized potentials following 
desialylation, while gating of the neonatal ventricular channel was unaffected.  
Figure 30 compares the voltage dependent parameters measured for each 
channel type ± desialylation / deglycosylation.  Note that none of the measured 
neonatal ventricular Nav gating parameters was significantly altered by  
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Figure 30:  Functional channel sialic acids can account for much of the 
developmental and chamber-specific changes in Nav gating parameters 
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Figure 30:  (continued) 
 
Bar graphs of the measured voltage-dependent Nav gating parameters for each 
myocyte type ± neuraminidase.  Each bar represents the average measured 
parameter ± S.E.M.  All values and significance listed in Table 1.  Black bars: 
control.  Light gray bars: neuraminidase treated.  Dark gray bars: PNGase-F 
treated.  NA: neonatal atria.  AA: adult atria.  NV: neonatal ventricle.  AV: adult 
ventricle.   
Panel A:  Voltage of half activation (Va) 
Panel B:  Voltage of half inactivation (Vi) 
Panel C:  Time constant of inactivation (τh) measured during a -50 mV test pulse. 
Panel D:  Time constant of recovery from inactivation (τrec) measured at a –120 
mV recovery potential. 
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desialylation / deglycosylation.  However, following desialylation / 
deglycosylation, all measured gating parameters for the atrial channels, both 
neonatal and adult, as well as the adult ventricular channel, shifted to 
depolarized potentials, similar in value to those measured for the neonatal 
ventricular Nav.   
 
Nav1.5 expressed with β1 in Pro5 versus Lec2 indicates β1 action on Nav1.5 
gating is sialic acid dependent 
     In order to directly compare the effects of β1 sialylation on Nav1.5 channel 
gating, the Pro5 / Lec2 CHO cell expression system was used.  Pro5 and Lec2 
cells are related CHO cells that produce proteins with differing amounts of 
posttranslationally attached sialic acids (Deutscher et al., 1984;Stanley, 
1985;Stanley, 1989).  The Pro5 cell is essentially a CHO cell allowing for normal 
protein sialylation.  The Lec2 cell is deficient in the CMP-sialic acid transporter 
thus sialic acid cannot enter the Golgi and be added to proteins. 
     When Nav1.5 was expressed alone in either of the two cells, whole cell 
recording indicated that none of the four tested gating parameters (Va, Vi, τh, τrec) 
was significantly different from one cell to the other (see Bennett, 2002 for 
details).  This indicates that in the Pro5 / Lec2 cell expression system Nav1.5 
gating is not significantly affected by α subunit sialylation.  That is, the added α 
subunit sialylation accomplished by the Pro5 cell is not sufficient to alter channel 
gating when compared to the Lec2 cell.  To test whether β1 has an effect on 
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Nav1.5 channel gating and if those effects are sialic acid dependent, the Nav1.5 α 
subunit was co-expressed with β1 in both Pro5 and Lec2 cells. 
     Figure 31 indicates that when the α and β1 subunits were co-expressed into 
the Lec2 cells there was no difference in channel activation, Va (fig 31A), or 
channel inactivation, Vi (fig 31B), when compared to the α subunit alone.  When 
co-expressed in the Pro5 cells, both Va and Vi were shifted in the hyperpolarized 
direction by 9 and 11 mV respectively.  These data indicate that β1’s influence on 
Nav1.5 steady-state activation and inactivation is sialic acid dependent. 
     The kinetics of channel inactivation and recovery from inactivation were 
studied next.  Figure 32A and B show that the Nav1.5 α subunit τh and τrec were 
unaffected when co-expressed with β1 in Lec2 cells.  Similar to Va and Vi, when α 
and β1 were co-expressed in Pro5 cells, τh was faster and τrec was slower.  β1 
sialic acids are indicated to be responsible for the observed changes in τh and 
τrec.  Together, steady-state and kinetic data gathered from α and β1 co-
expression experiments in Pro5 versus Lec2 cells indicate that β1 modulation of 
Nav1.5 gating appears to be sialic acid dependent.  All of the values can be found 
in Table 3. 
     In a final attempt to demonstrate that β1’s influence over Nav1.5 gating is sialic 
acid dependent, β1 was mutated to remove all four N-glycosylation sites through 
site-directed mutagenesis.  Removal of all four N-glycosylation sites thus 
removes all sialic acid from the protein.  When co-expressed with Nav1.5 in fully 
sialylating Pro5 cells, the β1 mutant failed to affect Va, similar to wild-type β1 co- 
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Figure 31:  β1 sialic acids cause a hyperpolarizing shift in Nav1.5 activation and 
inactivation 
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Figure 31:  (continued) 
 
Filled Squares / Solid Lines: α transfected into Pro5 cells.  Filled Circles / Solid 
Lines: α transfected into Lec2 cells.  Filled Squares / Dashed Lines: β1 co-
transfected with α in Pro5 cells.  Open Squares / Dashed Lines: β1 co-transfected 
with α in Lec2 cells. 
Panel A:  Steady-state activation (G-V relationships).  Data are the average peak 
current ± S.E.M. at a membrane potential and the curves are fits of the data to 
single Boltzmann relationships. 
Panel B:  Steady-state availability (hinf) curves.  Data are the mean normalized 
peak current ± S.E.M. measured during a maximally depolarizing test pulse 
following a 500 msec prepulse to the plotted potentials. 
(Johnson et al., 2004) 
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Figure 32:  β1 sialic acids increase the rate of fast inactivation while decreasing 
the rate of recovery from fast inactivation 
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Figure 32:  (continued) 
 
Filled Squares / Solid Lines: α transfected into Pro5 cells.  Filled Circles / Solid 
Lines: α transfected into Lec2 cells.  Filled Squares / Dashed Lines: β1 co-
transfected with α in Pro5 cells.  Open Squares / Dashed Lines: β1 co-transfected 
with α in Lec2 cells. 
Panel A:  Time constant of fast inactivation (τh). Data are the average τh ± 
S.E.M. as a function of membrane potential.  Curves are non-theoretical point-to-
point.. 
Panel B:  Voltage dependence of the recovery time constants (τrec).  Data are 
the average τrec ± S.E.M. at a -140, -130, and -120 mV recovery potential.  Lines 
are non-theoretical point-to-point. 
(Johnson et al., 2004) 
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expressed with α in Lec2 cells.  Proper surface expression of the β1 mutant was 
confirmed by tagging with GFP (see Johnson et al., 2004 for details).  The 
addition of the β1 mutant data strongly indicates that β1 modulation of Nav1.5 is 
sialic acid dependent. 
 
SDS-PAGE analysis indicates good expression and glycosylation of β1 
using the Pro5 / Lec2 mammalian expression system 
     In order to verify the expression of β1 in transfected Pro5 and Lec2 cells, 
immunoblot analyses of homogenized transfected Pro5 and Lec2 cells were run.  
Figure 33 compares β1 transfected Pro5 and Lec2 cells to those of GFP 
transfected controls.  Lanes 2 and 5 show GFP transfected Lec2 and Pro5, 
respectively, and there is an obvious lack of a band in the predicted 22 - 37 kd 
range as previously described (Patton et al., 1994;Sutkowski & Catterall, 1990).  
Lanes 1 and 4 shows β1 transfected Lec2 and Pro5, respectively, with each lane 
showing a clear band in the 22 - 37 kd range indicating good β1 expression 
throughout. 
 
Transfection with β1 fails to modulate neonatal ventricular Nav gating 
     To determine if the difference in Na+ channel gating in the developing 
ventricle is a β1-induced phenomenon, neonatal VCM were transfected with β1.  
Whole cell recordings studying Va and Vi for the transfected neonatal VCM were 
compared to that of untransfected controls.  Preliminary data indicates that  
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Figure 33:  Immunoblot of β1 transfected into Lec2 and Pro5 cells 
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Figure 33:  (continued) 
 
Lane 1 is β1 transfected into Lec2 cells.  Lane 2 is GFP transfected control in 
Lec2 cells.  Lane 3 is a molecular weight marker lane.  Lane 4 is β1 transfected 
into Pro5 cells.  Lane 5 is GFP transfected Pro5 cells.   Bands detected using 
β1Ab at a 1:200 concentration.  
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transfection of β1 has no significant effect on neonatal ventricular Nav Va (fig. 
34A).  This experiment also demonstrates the same lack of effect on Vi with β1 
transfection (fig. 34B).  Is it possible that, for some unknown reason at the 
studied age that β1 is not properly interacting with α on a physical level, or, could 
the apparently reduced capacity of the neonatal ventricle to sialylate proteins be 
responsible for the lack of effect of transfected β1 on Nav gating, similar to β1 
expressed in Lec2? 
 
SDS-PAGE analysis indicates adult ventricular expression of β1 exceeds 
that of atria and neonatal ventricle 
     Our recent work has implicated the β1 sialic acids to be its primary modulatory 
tool of action on various Nav gating parameters (Johnson et al., 2004).   
Immunoblot analysis of neonatal and adult rat ventricular and atrial homogenates 
were done to observe the relative amount of β1 present in each of the four 
samples for comparative analysis.  In figure 35, lanes 2, 3, 4, and 5 are neonatal 
ventricle, adult ventricle, neonatal atria, and adult atria, respectively.  It is clear 
that in a side-by-side comparison the adult ventricle possesses more β1 protein.  
The other three samples also contain trace amounts of β1.  In the ventricle, β1 
appears to be up regulated with development and differentially expressed 
between cardiac chambers. 
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Figure 34:  Preliminary results indicate that β1 transfection has no significant 
impact on neonatal VCM Nav activation or inactivation, potentially due to a lack of 
β1 subunit sialylation 
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Figure 34:  (continued) 
 
Filled Circles: Untransfected neonatal VCM.  Open Circles: Neonatal VCM 
transfected with β1. 
Panel A:  G-V relationships for neonatal VCM ± β1.  Data are the average 
normalized peak conductance ± S.E.M. at a membrane potential. Curves are fits 
of the data to single Boltzmann distributions.   
Panel B:  Channel availability (hinf) for neonatal VCM ± β1.  Data are the average 
normalized peak current ± S.E.M. measured during a 5 ms test pulse to +40 mV 
following a 500 msec prepulse to the plotted potentials.  Curves are fits of the 
data to single Boltzmann distributions.   
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Figure 35:  Immunoblot of β1 in neonatal and adult ventricle and atria 
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Figure 35:  (continued) 
 
β1 protein is most prominent in the adult ventricle when compared to the less 
dense bands seen in neonatal ventricle/atria and adult atria. 
Lane labels: NV: neonatal ventricle.  AV: adult ventricle.  NA: neonatal atria.  AA: 
adult atria.  Lane 3 is a molecular weight marker.  Bands detected using β1Ab at 
a 1:200 concentration. 
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Discussion 
 
Differential sialylation of the α subunit is a major contributor to 
developmental shifts in ventricular Nav gating not observed in atria 
     Comparison of Nav gating measured from neonatal and adult ventricle 
indicated that the adult channel gates at potentials about 10 mV more 
hyperpolarized than does the neonatal channel.  In addition, neonatal and adult 
atrial Nav were tested and, in contrast to ventricle, gated at similar potentials to 
each other and adult ventricle.  More importantly, this demonstrated a difference 
in Nav channel gating between neonatal atria and ventricle not seen in the adult.  
In response to these differences, I sought to explore what might be responsible 
for this Nav remodeling observed throughout development and between cardiac 
chambers.  It was hypothesized that development- and/or chamber- dependent 
changes in the amount of channel associated functional sialic acids might 
account for these observed shifts in gating.  Neuraminidase treatment was used 
to remove sialic acids from the cell surface expressed Nav of the ventricular and 
atrial cardiomyocytes.  None of the tested voltage dependent gating parameters 
for the neonatal ventricular Nav was affected by neuraminidase treatment.  When 
treated, all of the atrial and adult ventricular Nav gating parameters shifted to 
more depolarized potentials similar in value to those measured for untreated (or 
treated) neonatal ventricular Nav.  Also, neuraminidase treatment resulted in no 
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significant change in the channel activation slope values, Ka, for any of the tested 
conditions.  This implies no consequence of desialylation on the effective valency 
of the channel S4 gating charges that move in response to the changing electric 
field.  As a result, desialylation apparently alters the electric field sensed by the 
channel gating charges, not the charges themselves.  These results provided 
strong evidence that sialic acids, as part of N-glycosylation trees attached to the 
Nav channel, are responsible for the observed differences in gating. 
     To determine whether sialic acids are fully responsible for the gating 
differences observed between myocyte chambers and ages, desialylation was 
achieved via removal of the entire N-linked glycosylation trees attached to the 
channel.  Removal of N-linked sugars through PNGase-F treatment (Figure 28) 
indicated that all gating parameters for atrial and adult ventricular channels 
behaved nearly identically to those measured for the neonatal ventricular 
channel.  Similar to what was seen with neuraminidase treatment, PNGase-F 
treatment again resulted in no significant change in Ka for any of the tested 
conditions.  This indicates no additional outcome of deglycosylation on the 
effective valency of the channel S4 gating charges that move in response to the 
changing electric field.  The data suggest that the differences in Nav gating 
between neonatal heart chambers, and throughout ventricular development, can 
be accounted for by differential glycosylation, with changes in functional sialic 
acid levels being the most important.  That is, functional sialic acids can account 
for the majority of voltage-dependent gating differences observed, while removal 
of the full N-glycosylation structures can account for all measured shifts among 
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Nav.  It is possible that two distinct N-glycosylation dependent mechanisms are 
responsible for the hyperpolarizing shifts in Nav gating.  However, it is more likely 
that while neuraminidase treatment consistently removes functional sialic acids, it 
may not have removed all functional sialic acids for each cell studied, while 
PNGase-F treatment was much more effective.  If this were the case, the 
observed SA-dependent effects on gating would be underestimated, resulting in 
measured parameters that apparently did not fully shift with desialylation. 
     To strengthen the electrophysiological evidence, biochemical analysis was 
done to determine if atrial and adult ventricular Nav are more heavily sialylated 
than neonatal ventricular Nav.  Immunoblot analysis of the neonatal and adult 
atria and ventricular Nav α subunits revealed that the neonatal ventricular Nav 
was lighter in weight than the other three.  When the homogenates were exposed 
to PNGase-F, the resultant immunoblot weights for all four samples were now 
similar to each other, and to the predicted unprocessed weight of Nav1.5 
indicating no difference in isoform expression.  These results allow us to 
conclude that the initial difference in Mr observed for the four conditions is due to 
differences in posttranslational modification.  When treated with neuraminidase, 
gel shift analysis indicated that approximately 15 more sialic acid residues are 
attached to the atria and adult ventricular Nav than the neonatal ventricle.  These 
data are consistent with the biophysical measurements, suggesting that most of 
the differences in gating between neonatal ventricular Nav and the Nav expressed 
in atria and adult ventricle are the result of fewer functional sialic acids attached 
to the neonatal ventricular α subunit.  According to these findings the number, 
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and possibly location, of functional sialic acid residues added to cardiac Nav are 
regulated as a function of cardiac development and chamber.   Potentially this 
difference is due to changes in the activity level of many of the different 
sialyltransferase enzymes throughout development. 
 
Chronic versus acute channel regulation 
     Differential sialylation may potentially modulate Nav gating through two 
different mechanisms, acute or chronic.  In the case of acute regulation, various 
Nav α subunits, which are differently glycosylated / sialylated, might be 
expressed at various periods in the life of an excitable cell.  This difference in Nav 
α subunit sialylation may directly and differently alter channel gating and cellular 
excitability.  As previously noted, the primary neonatal and adult cardiac Nav α 
subunit isoform is believed to be the same gene product (Nav1.5).  However, the 
primary neonatal skeletal muscle Nav α subunit is Nav1.5 while the primary adult 
skeletal muscle Nav α subunit is the Nav1.4 isoform (Cohen & Barchi, 
1993;Messner & Catterall, 1985;Miller et al., 1983).  In addition, it was shown that 
the adult skeletal muscle α subunit isoform is more heavily glycosylated than the 
neonatal skeletal muscle α subunit isoform (Cohen & Levitt, 1993;Zwerling et al., 
1991;Kraner et al., 1989;Gordon et al., 1988;Roberts & Barchi, 1987).  To 
compare these two different Nav isoforms, a study comparing the sialic acid 
dependent gating of the heavily glycosylated Nav1.4 to the lesser glycosylated 
Nav1.5 in two types of CHO cell lines was done.  When expressed in Pro5 cells 
(fully sialylating CHO cells) versus Lec2 cells (sialylation deficient CHO cells) it 
 113 
 
was shown that Nav1.4 gating is much more sensitive to sialic acids than is Nav1.5 
gating.  The study went on to localize the functional sialic acid residues to the 
IS5-S6 loop of Nav1.4 (Bennett, 2002).  Thus, channel gating appears to be 
partially dependent on the “glycosylation signature” of the α subunit expressed.  
This means that skeletal muscle cells, at different periods in their development, 
may be differently excitable, dependent upon which Nav α subunit is expressed 
at the time.  This demonstrates how the number and / or location of sialic acids 
indeed vary from one α subunit to another, producing a potential spectrum of 
functional sialic acids among Nav α subunits that may directly and differently 
modulate channel gating acutely. 
     The data shown here are consistent with a second “chronic” mechanism by 
which differential channel sialylation modulates Nav gating.  In the case of 
chronic regulation, the glycosylation signature of the expressed channels of the 
cell are not modified through the expression of different α subunit isoforms, 
rather via changes in the level of sialyltransferase activity with respect to a single 
α subunit isoform.  Altered transferase activity would lead to altered levels of 
channel functional sialic acids thus affecting cellular excitability.  We show here 
that ventricular Nav gating shifts in the hyperpolarized direction with 
development, which can be abolished with neuraminidase treatment.  Using 
biochemical means it was shown that in the adult ventricle the Nav α subunit is 
apparently more heavily sialylated than the neonatal ventricular α subunit.  These 
data are consistent with a chronic increase in sialyltransferase activity in the 
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developing ventricular cardiomyocytes.  Also, a higher level of sialyltransferase 
activity in the neonatal atria versus ventricle can explain the increase in atrial α 
subunit functional sialylation.  Recently, our laboratory has had Gene Chip 
analysis performed on mouse atrial and ventricular myocytes done at neonatal 
and adult ages.  These data have yielded results consistent with our idea of 
chronic regulation.  In detail, the up regulation of sialyltransferase expression in 
the developing ventricle and between chambers of the neonatal heart was shown 
to be apparent.  With increased sialyltransferase activity, more functional sialic 
acids might be added to the α subunit, directly modulating the voltage at which 
atrial and developing ventricular Nav gate.   
 
Control of Nav gating by differential sialylation appears to be intra and inter 
tissue specific 
     Differential channel sialylation appears to be a mechanism by which cardiac 
Nav activity may be modulated throughout development or between cardiac 
chambers.  A recent study of Nav1.9 function in rat dorsal root ganglia, also 
reported developmental regulation of channel sialylation.  This study from the 
Waxman laboratory indicated that an apparent decrease in Nav1.9 sialylation 
through development as expressed in dorsal root ganglion (DRG) neurons was 
responsible for a depolarizing shift in the half-inactivation voltage for Nav1.9.  
More heavily sialylated neonatal Nav1.9 inactivated at more hyperpolarized 
potentials than did the adult Nav1.9.  Channel activation voltage was unaffected by 
this differential sialylation (Tyrrell et al., 2001).  Additionally, NCAM is an example 
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of another protein, not a voltage-gated ion channel, which is differentially 
sialylated throughout development, similarly to Nav1.9 becoming less sialylated 
with age.  Reports have indicated that the highly polysialylated neonatal NCAM, 
with its decreased adhesive function, serves to maintain the integrity of the 
developing neuroepithelium, while in the adult, the less polysialylated highly 
adhesive NCAM is used to stabilize the differentiated neural structures in the 
adult (Breen & Regan, 1988;Sunshine et al., 1987;Mccoy et al., 1985;Finne, 
1982;Hoffman et al., 1982;Rothbard et al., 1982).  Importantly, this is good 
evidence to support a possible role of sialic acid in modulating the actions of 
different elements in multiple unrelated processes.  Additionally, these reports 
and the data shown here lead to a rather provocative and novel finding:  chronic 
differential sialylation evidently modulates Nav gating throughout development in 
a tissue- and intra-tissue (cardiac atria vs. cardiac ventricle) specific manner.   
     The NCAM research showed that the differential sialylation of NCAM 
throughout the developing neuroepithelium appeared to be vital in the correct 
construction of the neural pathways.  The DRG study showed that only channel 
inactivation voltage was affected by apparently lower levels of sialic acid 
attached to the adult Nav1.9.  Here, the data indicate that adult ventricular Nav are 
apparently more heavily sialylated than neonatal ventricular Nav.  As a result of 
this increased sialylation, all tested voltage dependent gating parameters were 
shown to gate at more hyperpolarized potentials.  Speaking strictly of voltage-
gated ion channels, the opposing changes in Nav1.9 and Nav1.5 sialylation 
throughout the development of two different cell types suggest that channel 
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gating may be modulated chronically through enzyme regulated tissue-specific 
differential sialylation.  Furthermore, a lack of changing sialylation with atrial 
development suggests that the same isoform may be differently chronically 
regulated, or not, within the same organ system as well.  Here we observed 
essentially uniform hyperpolarizing shifts in all gating parameters with increased 
sialylation for adult ventricular Nav1.5 while the DRG study reported non-uniform 
depolarizing shifts for the lesser sialylated adult Nav1.9.  Therefore, in addition, 
these observations suggest that the modulation of Nav gating through chronic 
differential sialylation may be isoform-specific as well.    
 
Acute regulation of Nav gating via β1 expression 
     When one considers how the addition of other elements, such as auxiliary 
β subunits interacting with α subunits, and the additional sialic acids they may 
also bring to the area can affect channel gating, the situation can become even 
more complicated.  Nav1.5 has been shown to interact with β1 and β2 in the heart 
(Maier et al., 2004;Malhotra et al., 2004).  The effects of channel sialylation, more 
specifically on the Nav individual subunits, α and β1, that can be expressed 
together were examined in two ways.  It was hypothesized that the β1 sialic acids 
may further exert a modulatory effect on channel gating through a novel trans-
regulatory mechanism.  To do this the Nav1.5 α subunit was expressed with β1 in 
fully- and non-sialylating CHO cells and β1 alone in neonatal VCM.  The 
expression system studies showed that all of the measured effects of β1 on 
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channel gating were due to β1 sialic acids (Johnson et al., 2004).  Data gathered 
after transfecting β1 into neonatal rVCM revealed no change in gating from 
untransfected conditions.  This can possibly be explained in two ways, either the 
transfected β1 subunit did not interact with Nav1.5, or the lesser Nav sialylating 
neonatal rVCM also fails to fully sialylate β1 thus rendering it nonfunctional.  
Throughout various excitable tissues it has been shown that β1 processing and 
expression appears to be developmentally regulated (Sashihara et al., 
1996;Sashihara et al., 1995;Yang et al., 1993;Sutkowski & Catterall, 1990).  This 
potential use of auxiliary β subunits is another example of chronic and acute 
channel modulation via differential sialylation.  Changing levels of overall channel 
sialylation through changing levels of sialyltransferase activity will impact β 
subunits chronically, thus regulating channel gating.  At the same time, regulation 
of β expression levels may directly impact the level of overall channel associated 
sialic acids acutely regulating channel gating.  As a result of this regulation of β 
subunit sialylation, the excitability of the cell may be affected in a more controlled 
manner, producing a wide range of differentially sialylated Nav.  Unfortunately, 
the inability to identify in native cells the α/β complexes in real time, while 
studying Nav function in real time is a major hurdle in determining the total impact 
of such varying subunit combinations in vivo.  Perhaps the use of a fluorescent 
tagged antibody specific for β1 can be used to at least confirm, or not, the surface 
expression of β1 following expression in transfected cardiac myocytes. 
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Potential physiological impact of increased or decreased sialylation and 
future experiments 
     Here it is shown that functional sialic acids added to the developing ventricular 
Nav α subunit directly alter channel gating.  In addition, neonatal atrial Nav have a 
greater level of functional sialic acids than do neonatal ventricular Nav.  What 
might be the physiological role for such developmental and spatial remodeling? 
There are at least two mechanisms by which sialic acid dependent shifts in Nav 
gating might modulate cardiac Na+ channel activity such that the spreading 
depolarizing/repolarizing waves across the heart would be affected: 1) A 
hyperpolarizing shift and slight increase in the window current, and 2) A 
significant slowing of the rate of recovery from fast inactivation. 
     The distribution of channels between the open and inactivated states at a 
membrane potential affects the percentage of channels that are persistently 
active.  This distribution can be represented graphically by overlapping G-V and 
steady-state inactivation curves, and is referred to as the “window current” 
(Attwell et al., 1979).  The intersecting area under the curves represents the 
voltage range at which a small percentage of channels may be persistently 
active.  There are several reports that show point mutations of SCN1A and 
SCN5A cause depolarizing shifts in the voltage range of the window current that 
may be responsible for such maladies as epilepsy and arrhythmias (LQTS) 
(Spampanato et al., 2003;Abriel et al., 2001;Splawski et al., 2002).  It has been 
proposed that changes that act to depolarize the window current, either through 
subunit mutation or desialylation, can lead to LQTS by creating persistent inward 
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sodium current later in phase 2.  This inward current will then act against the 
beginning delayed rectifier outward current, extending phase 2 of the 
cardiomyocyte action potential and, therefore, increasing the L-Q time period.  
For the atrial and adult ventricular Nav, the window current will be about 10 mV 
more hyperpolarized than the neonatal ventricular Nav window current, caused 
by the sialic acid dependent hyperpolarizing shifts in the G-V and hinf curves for 
atrial and adult ventricular Nav.  This will cause persistent atrial and adult 
ventricular Nav activity to occur at more hyperpolarized potentials, thus impacting 
cardiomyocyte excitability in a positive fashion.  Potentially this may serve to 
create a more easily excitable cell, thus protecting the integrity of the spreading 
action potential, while, at the same time protecting the cells from LQTS 
abnormalities.  
     The sialic acid dependent slowing of the rate of recovery from fast inactivation 
likely directly affects cardiac excitability.  It is observed here that atrial and adult 
ventricular Nav recover from fast inactivation more slowly than do the neonatal 
ventricular Nav.  Also, atrial and adult ventricular Nav recovery rates increase with 
desialylation to values close to or faster than neonatal ventricular Nav recovery 
rates, indicating that the slower recovery rates are due to an increase in 
functional sialic acids.  This slower recovery rate will alter the effective time 
between successive depolarizing / repolarizing waves because of the 
redistribution of Nav among functional states toward a larger population of 
inactivated channels.  That is, at a short time following the initialization of a Nav 
kinetic cycle, the percentage of atrial and adult ventricular Nav still in the 
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inactivated state will be greater than the percentage of inactivated neonatal 
ventricular channels, thus extending the absolute refractory period.  This will 
directly affect the rate at which subsequent depolarizations might lead to 
activation of significant Nav.  Because a larger percentage of atrial and adult 
ventricular Nav remain inactivated for longer periods of time, these slower 
recovery rates will act to limit early after depolarizations (EADs), often considered 
a leading cause of tachycardias.  One study, published by Chen et al., showed 
that certain SCN5A mutations that cause familial idiopathic ventricular fibrillation, 
IVF, was the result of a 25-30% increase in the Nav1.5 rate of recovery at a -80 
mV recovery potential (Chen et al., 1998).  In this study, desialylation results in 
an even greater increase in sodium channel rates of recovery from inactivation 
than those resulting from the aforementioned SCN5A mutations.  Normally, as an 
action potential is propagated to the left and right ventricles the signal that meets 
in the middle is cancelled out due to the left and right ventricular myocytes now 
being in their respective refractory periods.  In the case of unidirectional 
conduction block, myocytes distal to the damaged area causing the block have 
not been excited by the myocytes proximal to the block.  As a result, the normally 
cancelled out signal is now allowed to propagate from the myocytes distal of the 
block to the proximal myocytes.  Under normal conditions the proximal cells are 
in their refractory periods, thus preventing reentry through the damaged area of 
the heart.  Under abnormal conditions resulting either from mutation or, in this 
case, reduced channel sialylation, the proximal myocytes, having recovered 
faster than normal from inactivation, fail to prevent reentry of the signal leading to 
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circus movement and potentially fatal ventricular fibrillation.  Thus, increased 
sodium channel sialylation leads to slower rates of recovery from fast 
inactivation, which will effectively slow the Nav kinetic cycle.  This will directly 
affect whether and what percentage of Nav from an individual myocyte will 
activate in response to the depolarizing / repolarizing waves propagating across 
the heart, thereby impacting heart rhythms.  Thus, the majority of changes in 
ventricular Nav gating throughout development and the difference in the 
newborn’s atrial and ventricular Nav gating can be attributed to differential 
channel sialylation that directly modulates cardiac voltage-gated sodium channel 
gating. 
     A physiological role for sialic acids in cardiomyocyte excitability has been 
demonstrated in a recent study (Ufret-Vincenty et al., 2001a).  Cardiac excitability 
and Nav gating were studied using a heart failure mouse model, a knockout of 
the muscle LIM protein (MLP).  When wild type ventricular myocytes were treated 
with neuraminidase they produced Na+ currents that gated similarly to those of 
untreated MLP-/- myocytes, which are apparently less sialylated.  This suggests 
that the observed extended action potential repolarization of the MLP-/- myocyte 
was caused in part by lesser sialylated Nav.  The knockout and neuraminidase 
treated wild type myocyte Nav both experienced a reduction and rightward shift in 
their window current.  In addition, the rate of fast inactivation was slowed for 
desialylated and MLP-/- myocytes.  Each of these gating effects is consistent with 
those described here for the SA-insensitive neonatal ventricular Nav, and for all 
desialylated conditions.  The authors concluded that the lesser sialylated Nav of 
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the MLP-/- myocytes might be responsible for the extended action potential 
duration and increased susceptibility to EADs observed in this study. 
     Thus, differential sialylation of Nav will likely impact cardiac excitability through 
one or more of the mechanisms described herein.  Increased Nav sialylation 
leads to slower rates of recovery from fast inactivation, effectively extending the 
refractory period, which should lower susceptibility to EADs.  Furthermore, the 
SA-dependent leftward shift in window current has been implicated in limiting 
action potential duration.   Consequently, increased sialylation may cause the 
initial wave of excitation to occur at smaller depolarizations, while serving to also 
limit and control subsequent excitability, thus acting to help modulate and 
regulate heart rhythm. 
     It is important to realize that this work is merely a small piece of the puzzle 
that describes cardiac excitability.  It has been shown that sialic acid 
glycosylation may be a strong modulator of cardiac Nav gating.  In this study the 
primary means used to test sialic acid’s influence on gating was with 
neuraminidase to remove cell surface expressed sialic acid residues, and 
PNGase-F to remove the N-glycosylation altogether.  Other substances, for 
example swainsonine or castanospermine, that prevent the addition of sialic 
acids to the protein from inside the cell may also be used as another means to 
desialylate Nav.  Other methods that can be used, similar to this idea of 
preventing sialylation first rather than removing it later, would be through the use 
of sialyltransferase deficient knock out mouse models.  Not only could such 
knock out studies investigate specifically the effects of sialic acid on cardiac ion 
 123 
 
channels, it could also allow for observations of phenotypic maladies that 
manifest due to the sialic acid deficiency.  It is true that without voltage-gated 
sodium channels there would be no fast response phase 0 and essentially no 
cardiac action potential.  However, it is impossible to contemplate the cardiac 
action potential without thinking about the other ion channels involved, potassium 
and calcium channels.  The cardiac iK+ is generated by a combination of inward 
rectifier, delayed rectifier, and transient outward voltage-gated K+ channels.  L-
type voltage-gated Ca2+ channels generate the cardiac iCa2+ forming the myocyte 
phase 2 plateau, and are responsible for the slow response phase 0 in nodal 
pacemaker cells.  To understand the impact of sialic acid on cardiac excitability 
we must first understand its impact on these voltage-gated K+ and Ca2+ channels 
too.  Future electrophysiological and biochemical studies, similar to the ones 
done here, investigating the biophysical effects of, and relative levels of 
functional sialic acids on these individual channels can be done.  Once 
completed, the individual sialylated vs. unsialylated data for each ion channel can 
be compiled and perhaps used to run cardiac simulations comparing the two 
conditions to each other.  Action potential measurements done on 
cardiomyocytes before and after desialylation may further provide more data that 
can help answer some of the questions regarding the true purposes behind ion 
channel glycosylation. 
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Summary 
     Here we see first hand the potential effects of ion channel sialylation with 
regards to channel gating and cellular excitability.  In this example there appears 
to be a consistent trend in biophysical properties for cardiac Nav when comparing 
fully sialylated to lesser sialylated channels.  In all tested biophysical parameters 
the existence of greater levels of functional sialic acids acted to create a more 
readily excitable cell while also appearing to serve a protective function for the 
heart against various electrical conduction and physical pumping pathologies.  It 
is possible that the atrial Nav are fully sialylated at birth to continually ensure a 
readily excitable atria providing for maximal ventricular filling to be accomplished 
in the allotted time before ventricular contraction, a desired optimal result at any 
atrial age.  At the same time the lesser sialylated conditions of the neonatal 
ventricle, serving to increase recovery from inactivation, may facilitate the more 
rapid basal heart rate of the smaller neonatal heart.  In the adult heart the reason 
for fully sialylated atrial Nav probably remains similar to that for the neonate.  In 
the adult ventricle, however, this increase in functional channel sialylation, when 
compared to the neonate, may in fact serve to increase the excitability of the 
myocytes aiding in the production of ventricular systole.  At the same time, due to 
the substantial increase in necessary conduction length in the larger ventricles, 
increased functional sialylation may likely aid in the prevention of the action 
potential from degrading before it fully spreads throughout the ventricles.  Finally, 
and possibly most importantly, increased adult ventricular Nav functional 
sialylation, through its resultant decrease in Nav rates of recovery from 
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inactivation, may help to prevent electrical disturbances of the ventricles that may 
otherwise result in the death of the animal. 
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Table 1.  Gating parameters for adult and neonatal cardiomyocyte Nav under  
 
conditions of full and reduced sialylation / glycosylation 
  
The mean gating parameter values ± SEM are listed.  Significance was  
 
determined using a two-tailed student’s t-test comparing sample groups as  
 
follows:  1) Untreated samples were compared to untreated neonatal VCM, 2)  
 
Treated samples were compared to: a) their untreated cell type, and b) neonatal  
 
VCM.  # = Not significant.   * = Significant (P < 0.02).   ** = Highly significant (P <  
 
0.01). 
 
Cell 
 
n Va 
(mV) 
Vi 
(mV) 
τh @ -50 mV 
(msec) 
τrec @ -120 mV 
(msec) 
 
Neonatal VCM 
Untreated 
 
11 
 
-46.1 ±1.0 
 
-87.8 ±1.5 
 
 
4.0 ±0.2 
 
7.9 ±0.3 
 
Neonatal VCM 
Neuraminidase 
 
11 
 
# 
-46.8 ±1.0 
 
# 
-88.7 ±1.2 
 
# 
4.9 ±0.4 
 
# 
7.9 ±0.6 
 
Neonatal VCM 
PNGase-F 
 
6 
 
# 
-49.5 ±1.5 
 
# 
-90.6 ±1.1 
 
# 
3.6 ±0.3 
 
# 
8.4 ±0.6 
 
Adult VCM 
Untreated 
 
8 
 
** 
-56.9 ±1.1 
 
** 
-97.1 ±2.7 
 
** 
2.8 ±0.1 
 
** 
13.7 ±1.9 
 
Adult VCM 
Neuraminidase 
 
8 
 
a**; b# 
-47.3 ±1.6 
 
a**; b# 
-83.8 ±2.1 
 
a**; b# 
4.7 ±0.7 
 
a**; b** 
5.4 ±0.7 
 
Adult VCM 
PNGase-F 
 
7 
 
a**; b# 
-48.3 ±2.0 
 
a**; b# 
-86.7 ±2.6 
 
a**; b# 
3.7 ±0.5 
 
a**; b# 
7.6 ±0.7 
 
Neonatal ACM 
Untreated 
 
17 
 
** 
-57.0 ±0.6 
 
** 
-100.0 ±0.7 
 
** 
2.2 ±0.1 
 
** 
18.1 ±1.2 
 
Neonatal ACM 
Neuraminidase 
 
13 
 
a**; b# 
-49.9 ±1.1 
 
a*; b** 
-95.4 ±1.8 
 
a**; b** 
3.2 ±0.2 
 
a**; b** 
13.2 ±1.7 
 
Neonatal ACM 
PNGase-F 
 
6 
 
a**; b# 
-47.2 ±2.0 
 
a**; b# 
-86.3 ±2.0 
 
a**; b# 
4.5 ±0.6 
 
a**; b# 
8.0 ±0.9 
 
Adult ACM 
Untreated 
 
13 
 
** 
-56.7 ±1.0 
 
** 
-96.7 ±1.5 
 
** 
2.0 ±0.1 
 
** 
14.5 ±1.5 
 
Adult ACM 
Neuraminidase 
 
11 
 
a**; b# 
-49.9 ±1.0 
 
a**; b# 
-91.3 ±0.9 
 
a**; b** 
3.3 ±0.2 
 
a**; b# 
9.7 ±0.8 
 
Adult ACM 
PNGase-F 
 
7 
 
a**; b# 
-50.0 ±1.0 
 
a**; b# 
-88.8 ±1.9 
 
a**; b# 
3.0 ±0.3 
 
a**; b# 
9.9 ±1.2 
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Table 2.  Gel shift analyses for neonatal and adult cardiomyocyte sodium  
 
channels under conditions of full and reduced glycosylation / sialylation 
 
 
Data list the mean Mr +/- SEM measured for neonatal and adult cardiomyocyte  
 
Nav α subunits.  For the untreated data and their comparison to the treated  
 
homogenates, significance was determined using a two-tailed student’s t-test  
 
comparing the atrial and adult ventricular α subunit Mr to the neonatal ventricular  
 
α subunit Mr.  ** = Highly significant (P < 0.01).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell 
 
n 
 
Untreated 
 
n 
 
PNGase-F 
 
n 
 
Neuraminidase
 
Neonatal 
Ventricle 
 
 
19 
 
 
246.5 ±0.8 
 
6 
 
** 
231.6 ±1.9 
 
13
 
** 
241.2 ±0.7 
 
Adult 
Ventricle 
 
 
18 
 
** 
251.8 ±1.2 
 
6 
 
** 
231.3 ±2.0 
 
12
 
** 
242.0 ±1.1 
 
Neonatal 
Atria 
 
 
12 
 
** 
252.2 ±0.5 
 
4 
 
** 
230.2 ±1.1 
 
8 
 
** 
243.1 ±0.6 
 
Adult 
Atria 
 
 
11 
 
** 
251.4 ±0.4 
 
4 
 
** 
230.7 ±1.2 
 
7 
 
** 
243.3 ±0.5 
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Table 3:  Gating parameters for Nav1.5 transfected with or without β1 in the fully  
 
sialylating Pro5 or sialylation deficient Lec2 mammalian cell lines 
 
 
 
 
 
 
The data are the mean parameter values ± S.E.M.  Significance was tested using  
 
a two-tailed student’s t-test, with each condition being compared to that  
 
measured for the fully sialylated α subunit alone.  ** = highly significant (p <  
 
0.005).  * = significant (p < 0.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell 
 
n 
Va 
(mV) 
Vi 
(mV) 
τh @ -40 mV 
(ms) 
τrec @ -120 mV 
(ms) 
 
Pro5 + α 
 
13 
 
-29.0 ±2.2 
 
-78.7 ±2.5 
 
2.8 ±0.4 
 
4.0 ±0.1 
 
Lec2 + α 
 
10 
 
-29.5 ±1.6 
 
-79.5 ±1.9 
 
2.4 ±0.2 
 
4.1 ±0.1 
 
Pro5 + α + β1 
 
11 
 
** 
-37.4 ±1.6 
 
* 
-86.1 ±3.2 
 
* 
2.0 ±0.1 
 
** 
5.6 ±0.3 
 
Lec2 + β1 
 
9 
 
-28.6 ±0.9 
 
-78.8 ±1.6 
 
2.9 ±0.2 
 
4.1 ±0.1 
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